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Abstract 
Mild traumatic brain injury (mTBI) has become a focal point within the medical community 
due to its increased prevalence in recent years.  Unfortunately, there is currently no 
neuroimaging technique able to accurately diagnose and monitor mTBI in-vivo. One 
technique that has shown great promise is neurite orientation dispersion and density imaging 
(NODDI). NODDI is a diffusion MRI (dMRI) technique used to characterize microstructural 
complexity through the compartmental modelling of neural water fractions into Intra-neurite, 
Extra-neurite and CSF volume fractions. The overreaching theme of this thesis was to 
validate NODDI in a preclinical setting to then be applied to imaging of early mTBI. In the 
first study, NODDI was shown to have high precision and repeatability both between and 
within subject. Furthermore, it was found that small biological changes (<5%) may be 
detected with feasible sample sizes for NODDI metrics indicating it to be a useful tool within 
the preclinical research setting at 9.4 Tesla. Following this validation NODDI was used to 
image the early stages of mTBI in a rodent model. NODDI was able to detect changes in 
neurite microstructure within the first hour on mTBI. Following this successful application, 
NODDI was applied to a rodent model of repetitive mTBI. Many athletes experience 
multiple mTBI’s over the course of a season and the cumulative effect of these injuries is still 
unknown. NODDI was successfully able to detect altered water diffusion characteristics in 
the brain of rodents following both a first a second mTBI. Converse to our hypothesis, the 
measured changes did not differ between the first and second impact on a group wise scale.  
These changes reinforce our previous findings showing an immediate change to the 
microstructure of the brain following an initial mTBI, and further this knowledge by 
indicating a heterogeneous individual response to the second mTBI. Further it was shown 
that some of these changes did not return to normal between the two injuries, potentially 
providing a window into the changes within the brain. 
Keywords 
Neurite orientation dispersion and density imaging, Diffusion magnetic resonance imaging, 
Mild traumatic brain injury, Neuroinflammation, Blood brain barrier disruption. 
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Lay Summary 
Mild traumatic brain injury (mTBI) has become an important public health concern as these 
injuries have become increasingly common in recent years. Unfortunately, there is no current 
medical imaging technique that allows accurate diagnosis and monitoring of mTBI. This is 
because many neuroimaging techniques such as computed tomography (CT) and positron 
emission tomography (PET) lack the specificity to identify the subtle damage present in the 
brains of those suffering from mTBI. Magnetic resonance imaging (MRI) is a good candidate 
to identify these changes due to its strong soft tissue contrast. One specific MRI technique 
that has shown promise in detecting subtle brain microstructural changes is neurite 
orientation dispersion and density imaging (NODDI). NODDI is able to quantify the density 
and spatial organization of various anatomical structures in the brain such as axons and 
dendrites and as such presents an opportunity to monitor brain health after injury. In this 
thesis, NODDI was first developed for use in a preclinical MRI setting. As animal models 
present a unique opportunity to study the extremely early stages of mTBI it was first 
necessary to redevelop this technique from clinical use in humans to rodent use in a 
preclinical MRI scanner. Once NODDI was validated for pre-clinical use it was then applied 
in the extremely early stages of a rodent model of mTBI. NODDI was able to detect changes 
in the neuronal structures of rodents within the first hour of mTBI, representing a potential 
opportunity to map out these changes over time. Following this successful application, 
NODDI was applied to a rodent model of repetitive mTBI, a model particularly relevant to 
sporting situations. Many athletes experience multiple mTBI’s over the course of a season 
and the cumulative effect of these injuries is still unknown. NODDI was able to detect 
extremely early changes in the brain of rodents after both a first and second mTBI. Further it 
was shown that some of these changes did not return to normal between the two injuries, 
potentially providing a window into the changes within the brain. 
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Chapter 1  
1 Introduction 
1.1 Background and Motivation  
Awareness of the immediate and long-term detrimental effects of mild traumatic brain 
injury (mTBI) has increased recently. Currently there is no pathognomonic test that 
allows diagnosis of mTBI and subsequent monitoring of recovery. Clinical assessments 
focus on self-reported patient symptoms but unfortunately provide little with regard to the 
underlying biological changes that lead to these symptoms [1–4]. Further, it is nearly 
impossible to study the immediate (1-2 hours) changes in a clinical setting as patients 
simply aren’t available for study during this time period. Thus, we are left with a vague 
understanding of the pathological processes taking place in the immediate stages of 
mTBI. To develop unbiased metrics of mTBI that can inform diagnosis we must 
understand the underlying metabolic and microstructural features of these injuries.  
Currently there are many medical imaging techniques available that can be used to non-
invasively image the body. Unfortunately though, most are unable to image mTBI as 
large scale changes such as expanding epidural hematoma are absent [5,6]. Magnetic 
resonance imaging (MRI) is ideally suited for imaging the soft tissues within the brain 
and thus is widely used in the study of mTBI [7,8]. Various MRI techniques have been 
carefully developed that provide accurate and detailed in-vivo information about changes 
in the structure [9,10], metabolism [11,12], and function [13,14] of the brain due to 
mTBI. Despite these capabilities, imaging mTBI in-vivo is still limited in individual 
patients due to small physical size and heterogeneous distribution of injury markers in the 
brain [15]. Moreover, many microstructural abnormalities such as white matter lesions 
are found in a large percentage of healthy middle-aged individuals, further compounding 
the difficulty in detection of microstructural changes specific to mTBI [16]. Thus, there is 
a need to develop techniques that are sensitive specifically to microstructural changes in 
mTBI. One modality that has been shown to be effective in the detection of 
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microstructural changes in mTBI is diffusion magnetic resonance imaging (dMRI). dMRI 
is a powerful magnetic resonance modality that can probe anatomical microstructure and 
structural connectivity within the normal brain and following injury or pathology [17]. 
dMRI has been used extensively to study various forms of brain injury including mTBI 
and has been able to detect alterations in diffusion patterns of water years after initial 
injury in the clinical setting [18–20], and within 4 hours of injury in the pre-clinical 
setting [21]. Despite this, no current studies have attempted to use dMRI withing the first 
hour following an injury. Furthermore, the changes in these metrics have been 
inconsistent due to the heterogeneous nature of mTBI pathological changes [22–26]. To 
disentangle these features various advanced biophysical models have been proposed 
which model the diffusion signal in a biologically relevant form such as the composite 
hindered and restricted model of diffusion (CHARMED), white matter tract integrity 
(WMTI), and neurite orientation dispersion and density imaging (NODDI) [27–29]. 
NODDI is a biophysical model that separates the dMRI signal into three unique 
compartments termed intra-neurite, extra-neurite and CSF compartments [30]. The intra-
neurite compartment is representative of dendrites and axons, while the extra-neurite 
compartment is comprised of various cell bodies, areas in close proximity to neurons, and 
glial cells. The CSF compartment is simply the area taken up by freely diffusing water. 
This model allows detection of neuronal changes separate from changes within the extra-
neurite compartment. Thus, NODDI is well situated to image mTBI in-vivo in an attempt 
to understand the various pathological processes taking places in the immediate stages 
following mTBI. 
1.2 Thesis Objectives and Organization 
This thesis describes the process by which NODDI has been used to image various 
pathological changes in mTBI in-vivo at 9.4 Tesla in a rodent model of traumatic brain 
injury (TBI). Contained in this work is the first quantification of the reproducibility of 
NODDI in a rodent model at 9.4 Tesla, the first time NODDI (or any dMRI technique) 
has evaluated the temporal changes of diffusion characteristics within the brain of a 
rodent from hours 1-4 following a mTBI, and the first time the effect of repetitive mTBI 
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on diffusion characteristics within the rodent brain has been quantified with NODDI (or 
any dMRI technique) within the first hour of both an initial and secondary mTBI. This 
thesis requires an understanding of neuroanatomy, mTBI, MRI, dMRI, and NODDI. 
Therefore, a brief review of the relevant neuroanatomy is described, specifically that 
needed for the discussion of TBI in chapter 1.3. In chapter 3 the focus will shift to an 
overview of MRI in isolation followed by a description of diffusion processes and dMRI 
in chapter 4. Finally, in chapter 5, I will show how dMRI can exploit biophysical models 
to create a biologically relevant image using NODDI.  
The overall objective of this work is to develop Neurite orientation dispersion and density 
imaging into a viable dMRI technique applicable to detection of subtle microstructural 
changes in pre-clinical rodent models of mild traumatic brain injury using high field 
MRI. We hypothesized that NODDI will be sensitive to early microstructural changes in 
the brain in a rodent model of mTBI. Secondary to this objective, we aimed to determine 
whether NODDI metrics provided greater sensitivity than standard dMRI metrics to 
changes in the brain following mTBI in a rodent model. The following provides a 
summary of the specific objectives contained within each chapter of this thesis.  
Chapter 2 characterizes the reproducibility of NODDI in a rodent model at 9.4 Tesla. 
When this work began, no attempt had been made to determine either the feasibility or 
reproducibility of obtaining NODDI metrics at 9.4 Tesla in a rodent brain. As ultra-high 
field MRI presents many unique challenges, such as increased main magnetic field 
inhomogeneity and physiological artefacts, it was necessary to first determine the 
reproducibility and the utility (as determined by necessary sample sizes and measurable 
biological effects) of NODDI in this model.  
Chapter 3 presents the first application of NODDI to a pre-clinical rodent model of mTBI 
at 9.4 Tesla. We hypothesized that NODDI would detect changes in water diffusion 
indicating changes in the microstructure of the brain within the first 4 hours of mTBI. 
Further, we hypothesized that NODDI would be more sensitive to these changes than 
standard DTI metrics.  
4 
 
In Chapter 4 we extend the model of rodent TBI used in Chapter 3 to study the early 
microstructural changes present in a rodent model of repetitive mTBI. We hypothesized 
that NODDI would be able to detect water diffusion changes indicating microstructural 
changes in a rodent model of repetitive mTBI 9.4 Tesla. Furthermore, we hypothesized 
that these changes would be unique after an initial and secondary mTBI.  
Finally, in Chapter 5, the findings of this thesis are summarized and synthesized, 
particularly the novel contributions of this work to the field.  A discussion of the current 
state of NODDI as a neuroimaging technique to study mTBI in both a clinical and pre-
clinical model is also provided. The thesis concludes with a discussion of future 
directions for this work. 
1.3 Neurons and Mild Traumatic Brain Injury  
1.3.1 Neurons, Glial Cells, and the Blood Brain Barrier 
The Nervous System may be broadly defined as the communication center of a body. 
Within the nervous system there are two major classes of cells: neurons and glial cells. 
Neurons process and transmit information within the nervous system in the form of an 
action potential, enabling communication throughout the body. Glial cells on the other 
hand provide mechanical and metabolic support to the neurons, amongst various other 
processes.  
Neurons are made up three distinct parts: a cell body (or soma), an axon, and dendrites. 
The cell body houses the nucleus and associated intra-neurite structures and acts to 
integrate and organize various input stimuli. The axon and dendrites may be collectively 
referred to as neurites and are mainly responsible for collecting stimuli from 
neighbouring neural cells (dendrites) and transmitting signals from the cell body to the 
synapse (axon). For a more in depth overview of the nervous system please refer to [31]. 
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Figure 1.1 - General representation of the neuron including cell body, axon dendrites 
and axon terminal. Here we term the axons and dendrites collectively as neurites. 
Glial cells are largely divided into two categories: microglia and macroglia, the latter of 
which contains astrocytes and oligodendrocytes. Glial cells reside in the space near 
neurons and function as the resident immune cells within the brain and act to modulate 
neurotransmission at the synaptic level [32]. Further, they act to form myelin and insulate 
neurons, supply nutrients and oxygen to neurons, destroy pathogens, and various other 
dynamic processes essential to the healthy functioning of the central nervous system [33–
35]. Additionally, in many pathological processes such as mTBI, glial cells are essential 
in mediation of the neuroinflammatory response [36]. 
In addition to neurons and glial cells, the blood vessels of the CNS possess unique 
properties which allow highly specific regulation of the movement of molecules, ions, 
and cells from the vasculature to the brain [37]. Termed the blood brain barrier (BBB), 
the properties of these blood vessels enable careful maintenance of homeostasis and 
protection from pathogens and toxins [38]. This control is highly coordinated and 
responds continuously and dynamically to various chemical and electrical stimuli to 
protect and support the brain and CNS [39].   
1.3.2 Neurons, Glia, and the Blood Brain Barrier during Mild Traumatic 
Brain Injury 
Traumatic brain injury (TBI) refers to a wide variety of damage to the brain caused either 
directly or indirectly by a sudden impact, generally to the head itself, resulting in the 
disruption of normal brain function [5]. TBI has a long history of study within the 
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neuroscience community. However, there is still no pathognomonic test that can be used 
to accurately diagnose or assess TBI. This is particularly important in mTBI, which lacks 
obvious pathological presentations during the early phase of injury when decisions 
regarding treatment and return to play in sport are most critical [40,41]. Many different 
efforts have attempted to develop diagnostic criteria through observation of the complex 
cascade of metabolic, physiological, and behavioral effects associated with mTBI, but 
currently with limited success [42–44]. Current diagnosis relies on patient self-reporting, 
and qualitative symptom assessment in an effort to manage recovery, which leaves the 
possibility of unknowingly biased and unreliable assessments [45,46]. Thus, to enable 
clinicians to offer accurate patient diagnosis and prognosis it is necessary to develop 
unbiased metrics of mTBI. This thesis attempts to elucidate such metrics by focusing on 
changes in tissue microstructure that may be associated with alterations to neurons, glia, 
and the blood-brain barrier in the very early phase of mTBI.  
There are many changes to neurons that have been shown to accompany mTBI. The most 
common is neuronal cell death [47], but many others have been observed such as axonal 
beading [48], and demyelination and remyelination [49]. Each of these processes has 
been shown in various stages and to various degrees in mild traumatic brain injury [50–
55]. Further, axonal beading and swelling has been shown to occur within the first hour 
of injury, albeit in varied models and to our knowledge not yet in a closed head model of 
mTBI [56,57]. Unfortunately, it is still unclear what effect these processes have in terms 
of assessing the severity of mTBI and subsequent recovery.  
In addition to neuronal changes, glial cells are known to act in both a neuroprotective and 
neurodegenerative manner over the course of injury and recovery in mTBI [58]. 
Following injury, microglia undergo morphological changes which can produce 
neuroprotective factors and coordinate neurorestorative processes or can become 
dysregulated and produce pro-inflammatory and cytotoxic mediators that hinder repair 
[59]. Astrocytes respond to mTBI by undergoing reactive astrogliosis which aims to limit 
tissue damage and restore homeostasis, but may also inhibit adaptive neural plasticity 
mechanisms underlying recovery [60,61]. Oligodendrocytes are uniquely vulnerable to 
damage under pathological processes and show various patterns of apoptosis and 
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dysfunction following mTBI [62–65]. Further, in the acute inflammatory phase BBB 
disruption and leakage takes place contributing to infiltration of blood-borne leukocytes, 
blood plasma proteins, and macrophages [66–68]. BBB disruption can occur within 
minutes following mTBI [69–71], with various neuroinflammatory processes occurring 
within several hours if initial injury [72,73].  
Despite the importance of these pathological processes in mTBI, much of our current 
knowledge is confined to ex-vivo histological samples leaving a gap in our knowledge of 
the dynamic properties of neurites, glial cells, and the blood brain barrier. As NODDI’s 
biophysical model separately quantifies the changes in neurite volume and orientation, 
this technique is well suited to detect and monitor the progression of changes in neurite 
structure in-vivo in mTBI. Further, neuroinflammatory processes and blood brain barrier 
disruption would take place within the extra-neurite compartment, once again allowing 
this technique to provide a detailed in-vivo look at the dynamic processes taking place in 
mTBI. Finally, as NODDI allows in-vivo imaging by which we might detect various 
dynamic changes within the neural microstructure, careful study of the immediate effects 
of mTBI on neurons, glia and the blood barrier to injury is possible. This in turn could 
lead a more thorough understanding of the nervous system’s response to mTBI and 
potential interventions to improve patient recovery and outcomes. 
1.4 MRI – Nuclei, Magnetization, and Avoiding Quantum 
Mechanics 
All discussions of MRI must first begin with the discussion of the phenomenon of nuclear 
magnetic resonance (NMR). While the bulk properties of MRI take place on a 
macroscopic level and are thus well explained in the realm of classical physics, it is 
important to understand (in brief) the basis of the quantum mechanical description of 
NMR and how we extend this description into the realm of classical physics. Thus, this 
first chapter begins with a brief description of the quantum mechanical properties of 
nuclei and magnetization and transitions into a discussion of bulk magnetization and 
manipulation of particle ensembles to generate a measurable NMR signal for use in MRI. 
8 
 
All discussions and derivations in this chapter rely heavily on those presented in 
references [74–77].  
1.4.1 Brief Description of “Spin” 
All atomic and sub-atomic particles possess an intrinsic property known as spin angular 
momentum, or simply spin. This quantum mechanical property is highly analogous to the 
classical property of the angular momentum of a sphere rotating about some axis. There 
are several distinctions though to be made: spin is an intrinsic property of a particle and 
quantized in discrete states. It does not, in fact, represent the physical motion (rotation) of 
the particle in question.  
1.4.2 Spin and the Magnetic Moment I – Quantum Mechanics  
Individual particle spin is a quantum mechanical phenomenon. Spinning charge produces 
a magnetic field and thus a magnetic moment 𝜇 in the direction of 𝐽 (the angular 
momentum of the proton) such that:  
 ?⃗? = 𝛾 ∙ 𝐽		 (1) 
Here 𝛾 is the gyromagnetic ratio, a proportionality constant dependent upon the nucleus. 
For hydrogen (particularly relevant in MRI),   
 𝛾 = 2.675	𝑥	10$ 𝑟𝑎𝑑 𝑠 ∙ 𝑇⁄  (2) 
The hypothetical measurement of a single spin relies on a quantum mechanical 
description of angular momentum such that 
 𝐽 = ℏA𝐼(𝐼 + 1) (3) 
Where	𝐼 is the spin quantum number of the nucleus and may only take on discrete half 
integer values (I = 0, 1/2, 1, 3/2, …), ℏ = 	ℎ 2𝜋⁄ , and ℎ = 6.6	𝑥	10!"# 𝐽𝑜𝑢𝑙𝑒 𝑠⁄  (Planck’s 
constant). Thus, by quantum mechanics, the magnitude of the magnetic moment of a 
particle is simply a constant: 
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 𝜇 = 𝛾ℏA𝐼(𝐼 + 1) (4) 
For MRI, and particularly diffusion weighted MRI, we generally focus solely on 
hydrogen nuclei that possess a spin quantum number 𝐼 = 	±	1 2⁄ . Therefore, we find for 
the hydrogen nucleus, there are two distinct energy states: 
 𝐽 = ±	ℏ√3 2⁄ 	 (5) 
 𝜇 = ±	𝛾ℏ√3 2⁄  (6) 
We say spin energy is quantized as only one of these two states may be observed for a 
single spin at a single moment in time. 
Without influence from external factors, the orientation of the magnetic moment 
is random. However, interaction of the magnetic moment 𝜇 with a magnetic field 𝐵O⃗  will 
cause 𝜇	to precess around 𝐵O⃗  such that the torque on the particle is defined as: 
 𝜏 = 	𝜇 	×	𝐵O⃗ 	 (7) 
This is true for each individual particle within the field. The torque may also be described 
by Newtons Second Law as the time rate of change of the angular momentum: 
 𝑑𝐽
𝑑𝑡 = 	
1
𝛾
𝑑𝜇
𝑑𝑡  
(8) 
Therefore, we obtain the following equation of motion for a spin in a magnetic field: 
 𝑑𝜇(𝑡)
𝑑𝑡 = 	𝛾𝜇
(𝑡) ×	𝐵O⃗ (𝑡) 
(9) 
The precessional frequency of the magnetic moment induced by the magnetic field, 
known as the Larmor Frequency is defined as: 
 𝜔% = 	𝛾𝐵% (10) 
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Further to this discussion, the quantization of energy tells us that the magnetic moment of 
a proton in an external magnetic field may be measured in only one of two states. The 
magnetic moment may precess around an axis parallel to the main magnetic field (known 
as the “spin up” state) or the magnetic moment may precess around an axis antiparallel to 
the main magnetic field (known the “spin down” state). While both states occur naturally, 
the spin up is at a lower energy state to the spin down, and thus preferentially populated. 
The distribution of the nuclei into these states will be discussed later and is governed by 
Boltzmann statistics. 
Thus, we see the basis for the origin of the magnetic moment due to spin angular 
momentum and its interaction with an external magnetic field in terms of quantum 
mechanics. This description of the magnetic moment is essential to understanding the 
basis of MRI, but the use of quantum mechanics is only necessary to this point. While a 
single nuclear spin is governed by these properties, a large ensemble of these spins may 
be accurately described by classical mechanics. In a typical imaging voxel within an MRI 
experiment, the number of individual water protons, or spins, is on the order of 1019. The 
use of quantum mechanics is not only unnecessary when dealing with the scales of MRI, 
it becomes impractical. This allows the departure from the rigorous quantum mechanical 
description of single particle spins, into the classical realm of an ensemble of these spins 
known as bulk magnetization,	𝑀OO⃗ . 
1.4.3 Spin and the Magnetic Moment II – Classical Description 
With the quantum mechanical description of spins in an external magnetic field 
described, we now move to a more relevant discussion in MRI imaging: Bulk 
Magnetization (𝑀OO⃗ ). 𝑀OO⃗  is simply defined as the total magnetic moment of an ensemble of 
N spins such that: 
 
𝑀OO⃗ = 	U𝜇&OOO⃗
'
()*
 
(11) 
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As discussed earlier, individual spins in an external magnetic field may take on one of 
two measured states: spin up or spin down, with the spin up state being the lower energy 
state. The population distribution of these states takes on the form of the Boltzmann 
distribution: 
 𝑁↑
𝑁↓
=	𝑒!∆. /0⁄ ≈ 1 +	
𝛾ℏ𝐵%
𝐾𝑇  
(12) 
Here 𝐾 = 1.38 x 1023 J/K is the Boltzmann constant and ∆𝐸 is the energy difference 
between the spin up and spin down states known as the Zeeman energy: 
 ∆𝐸 = 	𝐸↓ −	𝐸↑ = 	𝛾ℏ𝐵% (13) 
Noting M will simply be the difference of magnetization resulting from spin-up magnetic 
moments and spin-down magnetic moments, we arrive at: 
 
𝑀OO⃗ ≈ 	
𝛾2ℏ2𝑁↓𝐵%
4𝐾𝑇 ?̂? 
(14) 
Thus, we find that the statistical distribution of an ensemble of spins placed in an external 
magnetic field will produce a net magnetization vector 𝑀]3(𝑡) aligned in the direction of 
the external magnetic field, 𝐵O⃗ 	% 	= 	𝐵O⃗ 	%?̂?. This net magnetization, 𝑀]3(𝑡),  is said to 
precess about the main magnetic field, 𝐵O⃗ 	% 	= 	𝐵O⃗ 	%?̂?, according to the following equation 
of motion, known as the Bloch Equation [78]: 
 𝑑𝑀OO⃗ (𝑡)
𝑑𝑡 = 	𝛾𝑀
OO⃗ (𝑡) ×	𝐵O⃗ (𝑡) 
(15) 
This vector may be described by classical mechanics and is no longer quantized into 
discrete energy states (ie. it may now take on any orientation in three dimensions). From 
this point on all discussions of magnetization refer simply to this bulk magnetization, and 
no longer individual magnetic moments. 
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Equation (15) can be rewritten in terms of individual components: 
 𝑑𝑀3(𝑡)
𝑑𝑡 = 0 
(16) 
 𝑑𝑀4(𝑡)
𝑑𝑡 = 	𝛾𝑀5
(𝑡)𝐵3(𝑡) 
(17) 
 𝑑𝑀5(𝑡)
𝑑𝑡 = 	𝛾𝑀4
(𝑡)𝐵3(𝑡) 
(18) 
The solutions to these equations become: 
 𝑀3(𝑡) = 	𝐶 (19) 
 𝑀5(𝑡) = 	𝑀4 cos(𝜔t) 	+		𝑀5 sin(𝜔t)	 (20) 
 𝑀5(𝑡) = 	𝑀5 cos(𝜔t) 	−		𝑀4 sin(𝜔t) (21) 
Where C is a constant. In other words, in the presence of an external magnetic field, 
𝐵O⃗ 	% 	= 	𝐵O⃗ 	%?̂?, the longitudinal component of the magnetization (Mz) is simply constant 
while the transverse components (Mx and My) vary sinusoidally around the main 
magnetic field.  
1.4.4 The Bloch Experiments 
The Bloch equations derive their name from Felix Bloch who’s experiments represented 
a landmark in NMR and MRI development [79]. Bloch and his colleagues were able to 
detect the transverse component of the signal by placing a receiver coil such that 
magnetic flux through the coil was at a right angle to the main magnetic field (Bz) and 
measuring the small electrical current generated in this coil. Additionally, Bloch et al. 
followed this experiment by perturbing the magnetization with a second constant 
magnetic field (B1) at right angles to the main magnetic field. He found that this caused a 
transient measurable electrical signal in the receiver coil, that decayed at a rate specific to 
the individual material being studied. It was reasoned that the individual spin magnetic 
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moments were interacting with each other and with their environment, causing the system 
to release energy in a process termed relaxation. 
1.4.5 Relaxation Time Constants 
Felix Bloch defined two relaxation time constants; the spin-lattice and spin-spin 
relaxation time constants. These are denoted 𝑇* and 𝑇2 respectively. 𝑇* describes the rate 
at which the longitudinal component (ie	𝑀3(𝑡)) approaches its equilibrium value of 
magnetization 𝑀%, while 𝑇2 describes the rate at which the magnetization component 
orthogonal to the main field (ie	𝑀45(𝑡)) decays. Further to these, a time constant,  𝑇2∗, 
describes the rate at which the magnetization component orthogonal to the main field 
decays including the effect of local inhomogeneities in the main magnetic field. These 
time constants are largely dependent on the molecular environment as well as magnetic 
field strength and temperature. Inclusion of the relaxation terms above modify equation 
(15) such that we have: 
 𝑑𝑀OO⃗ (𝑡)
𝑑𝑡 = 	𝛾𝑀
OO⃗ (𝑡) ×	𝐵O⃗ (𝑡) − 𝑅(𝑀OO⃗ (𝑡) −	𝑀%) 
(22) 
Where 𝑅	is the relaxation matrix represented by: 
 
⎝
⎜
⎛
1
𝑇2h 0 0
0 1 𝑇2h 0
0 0 1 𝑇*h ⎠
⎟
⎞
 
(23) 
1.4.6 The Bloch equations 
The behaviour of the bulk magnetization 𝑀 in a static magnetic field 𝐵O⃗ 	% 	= 	𝐵O⃗ 	%?̂?  with 
relaxation terms can now be described. Equation (22) can be rewritten in terms of 
individual components as follows: 
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 𝑑𝑀3(𝑡)
𝑑𝑡 = 	𝛾l𝑀4
(𝑡)𝐵5(𝑡) −	𝑀5(𝑡)𝐵4(𝑡)m −	
𝑀3(𝑡) −	𝑀%
𝑇*
 (24) 
 𝑑𝑀4(𝑡)
𝑑𝑡 = 	𝛾l𝑀5
(𝑡)𝐵3(𝑡) −	𝑀3(𝑡)𝐵5(𝑡)m −	
	𝑀4(𝑡)
𝑇2
 (25) 
 𝑑𝑀5(𝑡)
𝑑𝑡 = 	𝛾
[𝑀3(𝑡)𝐵4(𝑡) −	𝑀4(𝑡)𝐵3(𝑡)] −	
	𝑀5(𝑡)
𝑇2
 
(26) 
These equations are derived in the cartesian coordinate system, or what is commonly 
referred to as the “laboratory reference frame”. It turns out that since the magnetization is 
constantly precessing at the Larmor frequency in the transverse plane, defining a 
“rotating reference frame” simplifies the required mathematics. Replacing 𝐵3(𝑡) by 
𝐵3_899(𝑡) = 	𝐵3(𝑡) + Ω 𝛾⁄ , where Ω is the angular frequency of the rotating frame, we 
transform the above magnetization equations into the rotating reference frame: 
 𝑑𝑀3(𝑡)
𝑑𝑡 = 	𝛾l𝑀4
(𝑡)𝐵5:(𝑡) −	𝑀5(𝑡)𝐵4:(𝑡)m −	
𝑀3(𝑡) −	𝑀%
𝑇*
 (27) 
 𝑑𝑀4(𝑡)
𝑑𝑡 = 	−	𝐵3_899
(𝑡)𝑀5(𝑡) −	𝛾𝑀3(𝑡)𝐵5:(𝑡) −	
	𝑀4(𝑡)
𝑇2
 (28) 
 𝑑𝑀5(𝑡)
𝑑𝑡 = 	−	𝛾𝑀3
(𝑡)𝐵4:(𝑡) +	𝐵3_899(𝑡)𝑀4(𝑡) −	
	𝑀5(𝑡)
𝑇2
 
(29) 
Note 𝐵: refers to the components of the magnetic field defined in the rotating reference 
frame. For the remainder of this chapter all equations and derivations will occur in this 
rotating frame unless explicitly stated otherwise. 
1.4.7 RF Pulses 
Up to this point we have discussed magnetic moments, bulk magnetization, and their 
behaviour in the presence of a static magnetic field. But how does this lead to an MR 
signal? To generate a usable signal, we must manipulate the magnetization using specific 
radiofrequency (RF) pulses. These, radiofrequency pulses can cause the magnetization to 
15 
 
be “rotated” into the transverse plane where, due to Faraday’s Law, can then induce a 
measurable signal in a nearby coil. 
While there are countless different RF pulse types used in NMR and MRI, we will 
illustrate the simplest example of the effect of a single sinc RF pulse that has a duration 
much less than that of 𝑇* and 𝑇2. If this RF pulse is applied along the x axis in the 
rotating frame equations ((27 - (29) now become: 
 𝑑𝑀3(𝑡)
𝑑𝑡 = −	𝑀5
(𝑡)𝛾𝐵4:(𝑡) 
(30) 
 𝑑𝑀4(𝑡)
𝑑𝑡 = 0 
(31) 
 𝑑𝑀5(𝑡)
𝑑𝑡 = −	𝑀3
(𝑡)𝛾𝐵4:(𝑡) 
(32) 
The solutions to these equations are given by: 
 𝑀3(𝑡) = 	𝑀% cos(𝜔4t) (33) 
 𝑀4(𝑡) = 	0 (34) 
 𝑀5(𝑡) = 	𝑀% sin(𝜔4t) (35) 
Where the 𝜔4 represents the frequency of rotation about the x-axis. If we denote 𝛼 = 𝜔4t 
we may generate a general matrix form for the magnetization in all three dimensions 
generated by an RF-pulse directed along the x-axis in our rotating frame: 
 
r
𝑀4(𝑡)
𝑀5(𝑡)
𝑀3(𝑡)
s = 	 t
1 0 0
0 cos	(𝛼) −sin	(𝛼)
0 sin	(𝛼) −cos	(𝛼)
u	t
0
0
𝑀%
u	 
(36) 
Thus when 𝛼 = 90°, 𝑀4(𝑡) = 0, 𝑀3(𝑡) = 0, and 𝑀5(𝑡) = 	𝑀%. While this is an 
extremely simplistic example, it helps to illustrate the potential to manipulate the bulk 
magnetization of an ensemble of spins placed in an external magnetic field.  
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1.4.8 Signal Detection 
According to Faraday’s Law of induction, a time varying magnetic field will generate a 
current in a surrounding wire. This is the basis of all NMR and MRI signals. Similar to 
the original Bloch experiment, receiver coils are placed such that the magnetic flux 
through the coil is at a right angle to the main magnetic field (Bz). As the magnetization 
vector is rotated from the longitudinal to the transverse plane and subsequently relaxes, 
the magnetic flux through the coil changes and we can measure the current induced. For a 
given magnetic field in the laboratory frame: 
 
ΦOOO⃗ ; =	 y 𝐵O⃗ (𝑟) ∙ 𝑀OO⃗ (𝑟, 𝑡)𝑑𝑟
<=(>	@:8@
 
(37) 
where Φ; is the magnetic flux through the coil, 𝐵(𝑟) is the magnetic field in the 
laboratory frame and 𝑀(𝑟, 𝑡) is the bulk magnetization vector. The voltage generated 
from this process is 
 𝑉(𝑡) = 	
−𝑑Φ;
𝑑𝑡  
(38) 
Thus, we can see how perturbing the magnetization vector induces a measurable 
electrical signal in the surrounding receiver coils.  
1.4.9 FID 
Once the magnetization has been rotated into the transverse plane due to excitation from 
an RF pulse, this magnetization may now be detected due to the voltage it produces in the 
receiver coil as described above. In most MR experiments the signal will take a form of a 
free induction decay (FID) described by: 
 
𝑠(𝑡) = 	 y 𝑀OO⃗ 45(𝑟, 𝑡)𝑒!(A(:⃗,E)𝑑𝑟
<=(>	@:8@
 
(39) 
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where 𝑀45 is the transverse magnetization, r is the vector in Cartesian space, and 𝜔(𝑟, 𝑡) 
is the frequency in our rotating frame.  
1.4.10 Spatial Localization I – Slice Selection 
We have shown how to manipulate the bulk magnetization to produce a measurable 
electrical signal by using RF pulses. The next step is to spatially encode the bulk 
magnetization to generate a usable image. This is accomplished using additional 
magnetic fields, known as gradients, to vary the z-component of the magnetic field 
strength along the different axes. Mathematically these gradients are defined as: 
 
𝐺3 =	
𝜕𝐵3
𝜕𝑧 , 𝐺4 =	
𝜕𝐵3
𝜕𝑥 , 𝐺5 =	
𝜕𝐵3
𝜕𝑦  
(40) 
Of particular importance is the effect the gradient has on the spins at a given position. 
Applying a gradient will increase or decrease the total magnetic field strength at a 
particular position within the laboratory frame according to the following equation: 
 𝐵(𝑖) = 	𝐵% + 𝑖 ∙ 𝐺( (41) 
where 𝑖 is either the x, y, or z dimension in scanner space. This change in magnetic field 
strength alters the Larmor frequency with the new frequency being spatially defined 
according to the position relative to the gradient: 
 𝑓(𝑖) = 	
𝛾
2𝜋 (𝐵% + 𝑖𝐺() 
(42) 
This allows the selective excitation of nuclei using band limited RF pulses. For example, 
if we apply the gradient described above, the Larmor frequency varies linearly along an 
axis (usually ?̂?). Therefore, we may “tune” our RF pulse such that we specifically excite 
certain slabs, known as slices, along the length of the longitudinal axis. Using carefully 
designed pulse sequences, the user may control the position, shape, and width of each 
slice. 
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1.4.11 Spatial Localization II – In-plane localization 
In-plane localization relies on two distinct gradients referred to as the phase-encoding 
gradient and the frequency-encoding gradient. These gradients induce a temporary 
change in the resonant frequencies of excited nuclei that in turn causes a phase shift in the 
rotating reference frame given by: 
 ∅ = 	−𝛾𝐺𝑡 (43) 
We apply this principle in two dimensions after our slice selective excitation, allowing us 
to localize our signal within a slice. 
First, in our “phase encode” direction a gradient is applied perpendicular to our main 
magnetic field causing a spatially dependent increase in the precessional frequency of the 
nuclei along the phase encode axis (Time A in Figure 1.2 below). After the gradient is 
removed (Time B), the nuclei return to their initial frequency but with various phase 
shifts, dependent on their position along the phase encode axis. In Figure 1.2 the phase 
encode axis has been depicted to be the y-axis in the rotating frame and the gradient 
strength is represented vertically. These nuclei are now said to be “phase encoded” and 
will maintain this phase shift until further gradients are applied or the MR signal decays. 
This process is repeated for varied phase encode gradient strengths to sample as many 
possible spatial frequencies within a given image.  
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Figure 1.2 - Illustration of phase encoding for spatial localization in the MR signal. At 
time A the phase encode gradient is applied leading to attenuation of the precessional 
frequency of the spins. Once the gradient is removed (time B), the spins return to their 
original frequency but with a spatially dependent phase shift. Thus, these spins are now 
phase encoded. Figure reproduced with permission from Picture to Proton. 
Finally, we apply a frequency encode gradient, perpendicular to the phase encode 
gradient. During the measurement of our signal the frequency encode gradient causes an 
accumulated phase shift dependent on the nuclei position on the frequency encode axis. 
This gradient is often referred to as our “readout gradient” as it is applied during the 
acquisition of our signal. If we sample our received complex signal in quadrature at 
discrete time intervals, we can recover both this phase and frequency. Thus, each data 
point represents a different “amount” of frequency encoding and corresponds to a 
different spatial frequency. By sampling this way, we can collect all the spatial 
frequencies in the frequency encode direction with a single RF excitation. 
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1.4.12 Fourier Transform and K-space 
When we measure the signal from our sample, we obtain a sinusoidal combination of all 
the sampled spatial frequencies over the course of a given excitation. By Fourier theory 
this signal can be decomposed into individual parts each representing a unique spatial 
frequency. We store this information in k-space. k-space is simply our raw data space 
where each data point represents a unique spatial frequency and the magnitude 
(brightness) of the point represents the relative contribution of that spatial frequency of 
nuclei to the resulting image. 
 
Figure 1.3 – Illustration of the k-space trajectory produced by the combination of phase 
encoding and frequency encoding used for spatial localization in MRI. Figure 
reproduced with permission from Picture to Proton. 
Figure 1.3 shows how our phase encode (GPE) and frequency encode (GFE) gradients 
allow us to “traverse” k-space. Immediately after our excitation RF pulse, we begin at the 
center of k-space (Point A), which represents the total signal irrespective of location. 
Generally, we store the signal in 2-dimensional Fourier space, where the axes (kPE, and 
kFE) represent the spatial frequencies in the phase encode and frequency encode 
directions of the image. We first move to a position along our kPE by applying a phase 
encode gradient, and then sample along this line varying our position on the kFE axis 
through application of a frequency encode gradient (from points B-D). This process is 
repeated for a set number of phase-encode steps to “fill” k-space. From k-space one may 
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apply a Fourier transform to reconstruct the k-space data back into a recognizable image 
as shown in Figure 1.4. 
 
Figure 1.4 - A) Representation of the combination of all spatial frequencies obtained 
from a given MR signal in k-space. B) MR image reconstructed by Fourier transform 
from the shown k-space data. Image reproduced courtesy of Allen D. Elster, 
MRIquestions.com. 
1.4.13 Spin Echo Pulse Sequence 
While there are countless pulse sequences and variations of pulse sequences, most pulse 
sequences fall into two categories; spin echo or gradient echo pulse sequences. To 
illustrate these pulse sequences, we use pulse sequence diagrams. On the vertical axis we 
represent gradient or signal strength and the horizontal axis represents time. In a spin 
echo pulse sequence (also known as Hahn Spin Echo [80]), two pulses are used, 
commonly a 90° excitation pulse followed by a 180° refocusing pulse. The first pulse tips 
the magnetization into the transverse plane (also known as excitation). Once in the 
transverse plane the individual spins tend to precess at different rates due to magnetic 
field inhomogeneities. By applying a 180° refocusing pulse those spins that precess faster 
will be reordered and are now behind. At some time, known as the Echo Time (TE), these 
spins will eventually catch up, forming a coherent signal known as an echo. We will find 
later that this pulse sequence is the backbone of the NODDI pulse sequence used in this 
thesis.   
A B 
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Figure 1.5 – Representative spin echo pulse sequence diagram. In the spin echo pulse 
sequence, a 180° refocusing pulse is used to invert the spins in the transverse plan, 
leading to rephasing known as an echo. 
1.4.14 Gradient Echo Pulse Sequence 
In a gradient pulse sequence, we apply a dephasing gradient along the frequency encode 
axis to speed up the dephasing of the spins in the transverse plane. To create a 
measurable echo, we then apply a gradient of opposite polarity and equal magnitude 
(termed a rephasing gradient), causing the spins to rephase and create our echo. By 
applying these gradients, we may speed up the formation of our echo as opposed to the 
spin echo pulse sequence, and thus gradient echo sequences form the basis of many rapid 
imaging techniques [81]. 
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Figure 1.6 – Representative gradient echo pulse sequence diagram. In the gradient echo 
pulse sequence, a dephasing and rephasing gradient of equal and opposite polarity is 
used to rapidly create an echo in our signal. 
1.5 Diffusion and MRI 
To this point, we have briefly described how an image is generated by manipulating 
protons of the water molecule with various magnetic fields and RF pulses. In this section 
we show how we may further manipulate the MR signal to measure how water moves 
within biological tissue. By doing this we are able infer various microstructural 
components of the brain and gain greater insight into the structural basis of brain 
function. In this section, a brief background of diffusion in biological tissues will first be 
introduced followed by the technical aspects and implementation of diffusion weighted 
MRI (dMRI). 
1.5.1 Introduction to Diffusion and Diffusion Weighted MRI (dMRI) 
This section will cover the basics of diffusion in a biological context. Much like relating 
the quantum mechanical description of magnetic moment to the bulk magnetization, we 
begin by giving a brief description of the microscopic properties of diffusion. However, 
within the context of MRI, the diffusion of water in tissue can be adequately explained on 
the macroscopic level and the need for the complex mathematics associated with 
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microscopic diffusion can be largely ignored. First the phenomenon of diffusion will be 
discussed and then diffusion will be related to the previous discussion of MRI to show 
how to produce image contrast related to diffusion in a biological medium. 
1.5.2 The Microscopic Description of Diffusion – Brownian Motion 
Diffusion by definition is the motion of molecules in a random pattern due to thermal 
motion. This process is also known as Brownian motion, named after Robert Brown, who 
published his observations in an 1827 paper of the apparently random motion of pollen 
grains immersed in a fluid medium [82]. While Brown discussed these observations, the 
exact mathematical description of these interactions may not be solved analytically. 
Similar to the previous description of spins in a magnetic field, when discussing 
ensembles of particles in a fluid medium, statistical methods can be used to bridge the 
gap from the microscopic to the macroscopic and provide a mathematical solution to 
macroscopic diffusion. 
1.5.3 Macroscopic Diffusion in an Isotropic Environment 
In 1855, Adolf Fick began to describe the phenomenon of diffusion, on a macroscopic 
scale, based on the concepts of flux and concentration gradients [83]. His first law states 
that particle flux 𝐽, in an isotropic fluid medium, will be directed from areas of high 
concentration to low concentration and will be proportional to the concentration of 
particles in the medium at a given point in space. Mathematically stated: 
 𝐽 = 	−𝐷∇O⃗ 𝑛(𝑟, 𝑡) (44) 
Here 𝑛(𝑟, 𝑡) is the concentration of particle at position r and time t and 𝐷 is simply a 
scalar value describing the rate of diffusion in the given medium. As the medium is 
isotropic, 𝐷 is the same in all directions. Fick’s second law uses conservation of mass to 
predict how diffusion will lead to concentration changes over time giving: 
 𝜕𝑛
𝜕𝑡 = 𝐷∇
2𝑛 (45) 
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Here concentration changes (𝜕𝑛 𝜕𝑡)⁄  within a volume are proportional to the second 
derivative of the concentration gradient (∇O⃗ 2𝑛) and the diffusivity (𝐷).  
In 1905, Einstein described the observations made by Brown and Fick, using the random 
walk model (ie. a stochastic process) [84] leading to a mathematical framework to 
describe Brownian Motion.  In this model, a path is described as a series of successive 
steps on a Cartesian grid and a step is defined as a move from one grid point to another 
and each possible step is weighted with equal probability. For example, in Figure 1.7 A) 
below, a two-dimensional random walk model is shown where each possible step has 
probability p = 1/4. As the number of steps grows, the end points for each successive run 
tends towards a Gaussian distribution. This is known as isotropic diffusion and the 
probability of finding a particle at a given point in space and time can be solved 
mathematically. This same situation is further shown Figure 1.7 B) in three dimensions 
where each step has probability p=1/8 (cube). 
Consider first an ensemble of particles in an isotropic medium. The probability density 
𝑃(𝑅O⃗ , 𝑡), that a particle will move distance, 𝑅O⃗ , in some time, 𝑡, can be computed by 
solving: 
 𝜕𝑃(𝑅O⃗ , 𝑡)
𝜕𝑡 = 	𝐷∇
2𝑃(𝑅O⃗ , 𝑡) 
(46) 
The solution to this equation, commonly now known as the ensemble average propagator 
(EAP) or diffusion propagator, is simply a Gaussian distribution [84]: 
 
𝑃(𝑅O⃗ , 𝑡) = 	
1
(4𝜋𝐷𝑡)" 2⁄
𝑒!
GHI⃗ G
!
#JE  
(47) 
where 𝐷 is the diffusion coefficient, D represents a measure of the squared particle 
displacement over time. In the isotropic medium described here, the diffusion coefficient 
is independent of direction, which is the definition of isotropic diffusion.  
In the biological context the diffusion coefficient is experimentally determined and based 
on the mass of the molecule and the temperature and viscosity of the medium. For water 
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molecules diffusing in water at 37°C, the diffusion coefficient has been determined to be      
3x10-9m2/s2 [87]. Therefore in 50 ms, approximately 32% of the water molecules will 
have moved 17 μm. whereas only 5% of them have travelled over distances greater than 
34 μm. [88].  
 
Figure 1.7 – Illustration of a random walk in A) 2-dimensions and B) 3-dimensions. In 
each image a single particle was allowed to diffuse freely according to the random walk 
model with n=100 steps and A) p=1/4 from the origin or B) p=1/8. The resulting point 
clouds show the endpoints for the diffusion of a particle after 1000 successive trials 
tending toward Gaussian isotropic diffusion. Reproduced with permission of Frank R. 
Lawrence from The Principles of Diffusion Tensor Imaging [77]. 
1.5.4 Macroscopic Diffusion in an Anisotropic Environment 
In the previous illustration, diffusion was in a purely isotropic medium, with no barriers 
present. This situation is rarely found in a biological medium, as barriers are generally 
present and rarely are there purely homogenous environments. Examples of barriers 
relevant to diffusion imaging include cell membranes and axonal fibres due to the 
associated timescales of the diffusion measurement (which we will find later to be 
approximately 50-100 ms and will be discussed in 4.7) [89]. When such barriers are 
present, diffusion will predominantly occur in a direction perpendicular to the barrier. 
Einstein’s relation may be extended in these cases to describe the directional variations in 
diffusion by: 
27 
 
 
𝐷 = r
𝐷44 𝐷45 𝐷43
𝐷54 𝐷55 𝐷53
𝐷34 𝐷35 𝐷33
s	 
(48) 
𝐷 is now defined by the diffusion tensor, representing anisotropic diffusion. This tensor 
is a positive definite, symmetric (𝐷0 = 𝐷) tensor. Otherwise stated this tensor allows us 
to mathematically describe diffusion with directional dependence, known as anisotropic 
diffusion.  
 
Figure 1.8 - Illustration of a random walk with hypothetical barriers present in A) 2-
dimensions and B) 3-dimensions. In each image a single particle was allowed to diffuse 
freely according to the random walk model with n=100 steps and A) p=1/4 from the 
origin or B) p=1/8. The resulting point clouds show the endpoints for the diffusion of a 
particle after 1000 successive trials tending towards anisotropic diffusion. Reproduced 
with permission of Frank R. Lawrence from The Principles of Diffusion Tensor Imaging 
[77]. 
1.5.5 Diffusion NMR and the Bloch-Torrey Equations 
Until now, the phenomenon of diffusion has not been related to the diffusion 
measurement made by MRI.  The Bloch equations described earlier do not account for 
the effects of the diffusion of water on the magnetization vector, and consequently do not 
provide a basis for the measurement of water diffusion in tissue by MRI. Early 
experiments in NMR provided the basis for diffusion weighted MRI. In 1956, H.C. 
Torrey accounted for the effects of diffusion in an NMR experiment, producing what is 
known as the Bloch-Torrey equation [90]: 
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 𝑑𝑀OO⃗
𝑑𝑡 = 𝑀
OO⃗ 	× 𝛾𝐵899 −	
𝑀4𝚤 +	𝑀5𝚥
𝑇2
−	
(𝑀3 −𝑀%)𝚤
𝑇*
+ ∇O⃗ ∙ (𝐷∇O⃗ 𝑀OO⃗ ) 
(49) 
This equation describes the time evolution of the transverse magnetic field incorporating 
the effect of diffusion of water in a biological medium.  
1.5.6 Stejskal-Tanner: The PGSE and b-value 
In 1965 Stejskal and Tanner introduced the Pulsed Gradient Spin Echo (PGSE) sequence 
to measure the diffusion coefficient D [91]. The sequence is diagrammed in Figure 1.9 
and based on the spin echo pulse sequence described previously. Important to note are 
two quantities unique to the PGSE and essential for diffusion measurements: 𝛿, the 
diffusion gradient duration and ∆, the duration between the two diffusion gradients. In 
this pulse sequence, two diffusion gradients are placed symmetrically on either side of the 
180° refocusing pulse. The phase change induced by the first gradient will be: 
 ∅* =	−𝛾(𝛿𝐺)𝑥* (50) 
where 𝑥* indicates the position of the particle as the diffusion gradient is applied and 𝐺 is 
simply the gradient strength. The phase change during the second pulse is: 
 ∅2 =	−𝛾(𝛿𝐺)𝑥2 (51) 
where 𝑥2 is the new position of the particle. 
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Figure 1.9 – Representative pulse sequence diagram for the PGSE sequence when no 
diffusion is present (A) and when the spins diffuse (B). Here 𝜹 is the diffusion pulse 
duration and ∆ is the duration between the two diffusion pulses. When no diffusion is 
present, the diffusion gradients act equally and opposite on either side of the refocusing 
pulse and all spins rephase to create a full echo. When diffusion is present, the diffusion 
gradients have unequal effects on either side of the refocusing pulse, thus leading to a 
reduced echo. 
If a particle has not moved (ie. no diffusion has taken place), the phase changes caused by 
the two diffusion gradients will cancel resulting in no signal attenuation. Stejskal and 
Tanner showed that if a particle moved during or between the diffusion gradients, the 
magnetization, and therefore the signal 𝑆(𝑟), would be attenuated giving: 
 
𝑆(𝑟) = 	𝑆%(𝑟)𝑒
K!L!|N|!O!P∆	!	O"QJR 
(52) 
Commonly in Diffusion Weighted Imaging, several terms above are collected into a 
single “b-value”, a term coined by Le Bihan [92]: 
 
𝑏 = 𝛾2|𝐺|2𝛿2 ∆	−	
𝛿
3 
(53) 
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This b-value is user defined and indicates the amount of diffusion “weighting” that 
attributed to a diffusion imaging pulse sequence. Now Equation (53) reduces to: 
 𝑆(𝑟) = 	𝑆%(𝑟)𝑒[!TJ] (54) 
Simply put, diffusion of water during the time course of the pulse sequence leads to 
measurable signal loss. 
1.5.7 Diffusion Timescales 
So, what are these pulse sequence timescales and why do these scales uniquely lend 
themselves to applications such as neuroimaging? Table 1.1 shows some representative 
(but by no means exhaustive) values of axon diameter, cell body diameter, and extra 
axonal space (ie space between neighbouring axons) in both rats and humans. We term 
these unique areas as microstructural environments. The typical diffusion time in a 
diffusion experiment is determined from various pulse sequence parameters and largely 
ranges from 20-100 ms [88]. In that time the mean water displacement will range from 1 
- 15 µm, which allows for enough diffusion to differentiate between each of the 
microstructural environments below. Therefore, over the course of a diffusion pulse 
sequence, the signal is weighted by not just diffusion, but the relative contribution of 
diffusion within each of these microstructural environments. 
Table 1.1 - Representative values of human and rat microstructural features and 
diffusion parameters. 
Quantity Humans Rats 
Axon Diameter in Corpus 
Collosum 
0.5 – 5.0 
µm [93] 
0.4 – 3.0 µm 
[94,95] 
Neuron Cell Body Diameter < 50 µm [96] 
< 15 µm 
[97,98] 
Extra Axonal Space  
8 µm [99] 
(internal 
capsule) 
not available  
Diffusion time in DTI 50 - 100 ms [88] 
Mean Water Diffusion Distance 1 - 15 µm [100] 
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1.5.8 Diffusion-Weighted Imaging (DWI) and the Apparent Diffusion 
Coefficient (ADC) 
With this in mind, in 1990, Moseley et. al., attempted to describe directional diffusion 
[101]. Combined with an “unweighted” image (ie. one lacking any diffusion gradient), 
the metric called apparent diffusion coefficient (ADC), may be obtained: 
 𝑙𝑛	(𝑆(𝑏))
𝑆%
=	−𝑏	 ∙ 𝐴𝐷𝐶 
(55) 
By measuring this ADC in multiple directions, a measure of anisotropy may be obtained. 
Initially, Moseley et al. proposed a metric based on ADCz/ADCx, requiring two DWI’s 
[101]. This method suffered though as it was rotationally variant, and largely depended 
on the gradient encoding directions.  
1.5.9 Diffusion Tensor Imaging   
In an attempt to overcome the rotational variance, in 1994 Basser et al. proposed the use 
of the diffusion tensor to characterize the local diffusion within a voxel [102]. The 
diffusion tensor is given by: 
 
𝐷 =	 r
𝐷44 𝐷45 𝐷43
𝐷54 𝐷55 𝐷53
𝐷34 𝐷35 𝐷33
s 
(56) 
This is the same tensor used by Einstein to describe Anisotropic Gaussian diffusion. 
Thus, this tensor allows us to determine the magnitude and direction of diffusion in three 
independent directions within a given imaging voxel. 
1.5.10 The Diffusion Tensor (Imaging) Metrics 
Commonly there are several scalar metrics one may extract from the diffusion tensor: 
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Trace: The trace provides a metric of the magnitude of the diffusion tensor. 
Mathematically the trace is simply the sum of the individual eigenvalues of 𝐷: 
 𝑇𝑟𝑎𝑐𝑒	(𝐷) = 	𝜆* +	𝜆2 +	𝜆" (57) 
Here 𝜆*, 𝜆2, and 𝜆" represent the principle, secondary and tertiary eigenvalues 
respectively. 
Mean Diffusivity (MD): MD is a metric indicating the overall magnitude of diffusion, or 
simply the average of the eigenvalues of 𝐷: 
 𝑀𝐷𝐷 = 	
𝜆* +	𝜆2 +	𝜆"
3  
(58) 
Axial Diffusivity (MD):  For a directionally dependent diffusion tensor, the axial 
diffusivity may simply be defined as the magnitude of diffusion along the longitudinal 
(principle) axis of the tensor: 
 𝐴𝐷𝐷 = 	𝜆* (59) 
Radial Diffusivity (MD): For a directionally dependent diffusion tensor, the radial 
diffusivity is the average diffusion radiating in the transverse directions of the tensor 
(secondary and tertiary eigenvalues): 
 
𝑅𝐷𝐷 = 	
𝜆* +	𝜆2
2  
(60) 
Fractional Anisotropy (FA) is a metric ranging between 0 and 1 and describes the 
degree of directionality of the diffusion tensor. An FA value of 0 indicates purely 
isotropic (Gaussian Diffusion) while a value nearing 1 indicates highly directional 
diffusion. FA is mathematically determined as: 
 
𝐹𝐴𝐷 = 	
(𝜆* −	𝜆2)2 +	(𝜆2 −	𝜆")2 +	(𝜆" −	𝜆*)2
2(𝜆*
2 +	𝜆*
2	+	𝜆*
2)
 
(61) 
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Figure 1.10 - Representative depictions of the diffusion tensor as an ellipsoid. A) 
Isotropic Gaussian diffusion, l1=l2 =l3; FA = 0 B) l1 >l2 ,l3 , 0 < FA < 1. 
1.5.11 Shortcoming of dMRI and DTI 
Since its introduction, DTI has largely become the standard for diffusion weighted 
imaging protocols. The applications have become widespread, including, but not limited 
to, brain injury [103,104] neurodegenerative disease [105,106], behaviour [107] and even 
cardiac imaging [108]. Indeed, DTI has become a powerful tool by which researchers 
may infer underlying tissue microstructure. Despite this utility, DTI suffers from some 
limitations. Each marker obtained provides a localized metric of average water diffusion 
from which subsequent analysis relies on inference for a conclusion.  Thus, while 
powerful, DTI lacks the specificity to identify unique microstructural environments (such 
as those listed in 1.5.7). Without this information DTI cannot distinguish between distinct 
processes such as loss of structural integrity or neural remodelling, and thus leads to an 
inherently vague and limited model of neuroanatomy [109]. To this end, more 
sophisticated dMRI acquisition and reconstruction techniques have been developed to 
overcome the limitations of DTI one of which is neurite orientation dispersion and 
density imaging (NODDI) [29].  From here the focus of this thesis will be on NODDI. 
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1.6 Neurite Orientation Dispersion and Density Imaging  
The following sections discuss neurite orientation dispersion and density imaging 
(NODDI) and how it may offer an improvement over traditional dMRI techniques such 
as DTI by reconstructing tissue microstructure directly from the diffusion MR signal. The 
equations and metrics derived in this section follow those presented in [29,30] 
1.6.1 NODDI Tissue Model  
NODDI uses a biophysical tissue model with three separate non-exchanging 
microstructural compartments: intra-neurite, extra-neurite and CSF. NODDI 
distinguishes between each compartment based on the diffusion characteristics of each of 
these distinct environments. The intra-neurite space refers to the space taken up by 
dendrites and axons collectively. The diffusion in this space is unique in that it is highly 
restricted in any direction perpendicular to the long axon of a neurite, while it is 
unhindered in a direction parallel to it.  Conversely, within the space surrounding the 
neurite, largely comprised of glial cells, cell bodies and in the case of mTBI various 
blood borne proteins, diffusion is hindered but much less so than in the intra-neurite 
space. Thus, this diffusion may be described as simple anisotropic Gaussian diffusion. 
Finally, the CSF or isotropic compartment is simply the space taken up by cerebrospinal 
fluid and modeled as isotropic Gaussian diffusion. 
1.6.2 NODDI Signal Equation 
In this work a PGSE pulse sequence as described in the 1.5.6 is used to generate the 
NODDI signal. Based on the three-compartment model described above, the full acquired 
signal S is normalized as: 
 𝑆 = 	𝑣(V=𝑆(V= + (1 − 𝑣(V=)(𝑣(W𝑆(W + (1 −	𝑣(W)𝑆8W) (62) 
Here, 𝑆W is the signal belonging to each characteristic microstructural compartment, and 
𝑣W is the volume fraction of water belonging to each characteristic microstructural 
compartment. Here 𝑖𝑠𝑜, 𝑖𝑛, and 𝑒𝑛 indicate the isotropic, intra-neurite and extra-neurite 
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compartments respectively. Each compartment has a characteristic signal component that 
may be described individually.  
First, the signal from the isotropic compartment is separated from the full signal equation 
(ie. CSF compartment). This is simply modelled as signal decay due to isotropic diffusion 
with diffusivity 𝑑(V=: 
 𝑆(V= =	𝑒!TX"#$ (63) 
The intra-neurite component 𝑆(W is defined as a set of “sticks” of zero radius and parallel 
diffusivity 𝑑∥ distributed in space according to the Watson distribution and 
mathematically defined as: 
 
𝑆(W =		y 𝑓(𝑛O⃗ )𝑒!TX∥(ZI⃗ ∙WI⃗ )
!𝑑𝑛O⃗
\!
 
(64) 
Here 𝑒!TX∥(ZI⃗ ∙WI⃗ )! describes signal attenuation due to a given b-value,	𝑏, gradient direction, 
?⃗?, and diffusion direction, 𝑛O⃗ , while 𝑓(𝑛O⃗ )𝑑𝑛O⃗  is the probability of a given neurite having an 
orientation within 𝑑𝑛O⃗ , an infinitely small cone centered around 𝑛O⃗ 	 ∈ 	 𝑆2 → ℝ]. Following 
the work of Zhang et al. [30], the orientation distribution function, 𝑓(𝑛O⃗ ), follows a 
Watson distribution: 
 
𝑓(𝑛O⃗ ) 	= 	𝑀 
1
2 ,
3
2 , 𝜅
!*
𝑒^(_I⃗∙WI⃗ )! 
(65) 
Here M is a confluent hypergeometric function, ?⃗?, is the mean orientation and 𝜅 is the 
concentration parameter that quantifies the orientation dispersion about ?⃗?. 
The extra-neurite signal component, 𝑆8W, is modelled as attenuation due to anisotropic 
Gaussian diffusion: 
 𝑆8W =	𝑒
!TZI⃗ &`∫ 9(WI⃗ )J(WI⃗ )XWI⃗'! bZI⃗  (66) 
Here 𝐷(𝑛O⃗ ) is a cylindrically symmetric tensor, with parallel diffusivity 𝑑∥, perpendicular 
diffusivity 𝑑c and principle diffusion orientation along 𝑛O⃗ . As in [29], the parallel 
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diffusivity matches that of the intra-neurite compartment, with the perpendicular 
diffusivity set using a tortuosity model [110] as 
 𝑑c 	= 	𝑑∥(1	 −	𝑣(W) (67) 
The orientation dispersion index (ODI) is defined as a value ranging from 0-1 according 
to the concentration parameter of the Watson distribution 𝜅 
 𝑂𝐷𝐼	 = 	
2
𝜋 𝑎𝑟𝑐𝑡𝑎𝑛(
1
𝜅) 
(68) 
1.6.3 NODDI Fitting 
The NODDI fitting routine fixes the diffusivity values 𝑑∥ = 1.7 x 10-3 mm2/s and            
𝑑(V= = 3.0 x 10-3 mm2/s. The following parameters are then estimated to solve the above 
equations: 𝑣(W, 𝜅, ?⃗?, and 𝑣(V=. Briefly, the fitting procedure first follows a brute-force 
search over a grid of physically plausible values based on known tissue properties. The 
results of this initial search are then used as a starting point for a Gauss-Newton nonlinear 
optimization procedure, using a Rician noise model, to produce the maximum likelihood 
estimates of the parameters listed above.  
1.6.4 NODDI Acquisition 
The NODDI acquisition scheme relies on a multi-shell acquisition scheme. Multi-shell 
refers to the use of multiple b-values and offers distinct advantages to the single shell 
acquisition (single b-value) employed in DTI. Higher b-value ( > 1000 s/mm2) images 
have been shown to increase contrast between gray matter and white matter and better 
elucidate the smaller microstructural features in white matter but suffer from low signal 
to noise ratio [111–113]. Lower b‐value images ( < 1000 s/mm2) on the other hand 
provide a higher signal‐to‐noise ratio (SNR) and more anatomic information [114]. By 
using multiple b-values, we are able to gain both advantages and encode more detailed 
features of the cellular environment within our dMRI signal, with the caveat of increased 
acquisition time [115,116]. In 2012, Zhang et. al. provided the seminal work for the 
optimization of the NODDI acquisition [29]. It was shown for NODDI metrics to be 
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accurate and precise with only two moderate non-zero b-values. In simulation the optimal 
choice of these b-values to be 711 s/mm2 and 2855 s/mm2 but in-vivo the precise choice 
of these b-values had little effect on the resulting NODDI metrics. Finally it was also 
shown that the precise distribution of directions of b-values within and between shells 
had limited effect on the resulting parameters provided sufficient angular resolution was 
achieved (while sufficient was not expressly quantified within this paper, by convention 
it is taken to be a HARDI [117] acquisition with > 50 total gradient directions). While 
this study was performed in humans, it also showed quantitatively that all microstructural 
parameters were minimally affected by axon diameter lending this application to non-
human models. 
1.6.5 NODDI Metrics 
From the above signal equations, the following scalar metrics may be obtained: 
Neurite Density Index (NDI): Neurite density Index is a scalar value ranging from 0 to 
1 and represents the volume fraction of the diffusion signal originating from within the 
axons and dendrites. 
Orientation Dispersion Index (ODI): Orientation dispersion index is a scalar value 
ranging from 0 to 1 and represents the dispersion of the modelled “sticks” of the intra-
neurite compartment. A value near 0 represents highly aligned and coherent fiber bundles 
(ie white matter tracts of the corpus collosum), while a value towards one represents 
widely dispersed fibers (ie grey matter).  
Extra-Neurite Volume Fraction: The extra-neurite fraction represents the volume 
fraction of the diffusion signal originating from anisotropic gaussian diffusion. This 
would be indicative of diffusion near neurons and axons and within cell bodies. This is a 
simple 1-NDI, and thus varies inversely with NDI as a scalar value. 
Isotropic Volume Fraction (IsoVF): Isotropic volume fraction is a scalar value from 0-1 
and represents the signal originating from freely diffusing water. Within the nervous 
38 
 
system, this can largely be attributed exclusively to the CSF, but may also arise from 
pathological processes such as Edema.  
 
Figure 1.11 - Representation of the relevant NODDI metrics obtained from a multi-shell 
PGSE signal within a given imaging voxel. Notice the diffusion signal may be 
simultaneously reconstructed to produce DTI metrics. 
1.6.6 NODDI in Traumatic Brain Injury  
As discussed in Chapter 2, many neuropathological changes are evident in various stages 
of mTBI, of which NODDI may be well situated to detect due to the nature of the multi-
compartmental biophysical model. Pathological processes such as axonal beading lead to 
an increase in NDI as the inner diameter of the axon expands, whereas demyelination 
would lead to a decrease in NDI.  Separate changes within the extra-neurite compartment 
such as neuroinflammatory effects may lead to increased NDI. Thus, NODDI is uniquely 
situated to image mTBI in-vivo in an attempt to understand the various pathological 
processes taking places in the immediate stages following mTBI. 
To this point though, the use of NODDI in traumatic brain injury studies has been 
undertaken exclusively in the clinical realm and to our knowledge, limited to a select few 
studies. Table 1.2 below summarizes the currently available studies applying NODDI to 
brain injuries and the relevant changes in NODDI metrics found in each study with 
respect to matched controls. 
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Table 1.2 - Summary of the currently published work applying NODDI in traumatic brain 
injury and concussion.  
Study Study Participants 
Imaging 
Time Post-
Injury 
NDI ODI IsoVF 
[118] 
Athletes with a 
history of 
concussion 
(male and 
female) 
> 6 months 
post-
concussion 
Increase (left 
anterior corona 
radiata and 
proximal to the 
left superior 
corona radiata) 
Decrease (left 
anterior corona 
radiata. 
Splenium of the 
corpus 
callosum, 
superior 
longitudinal 
fasciculus 
None 
[119] 
Athletes 
during 
concussion 
recovery (male 
and female) 
1-7 days post-
concussion 
Decrease 
(corona radiata 
and longitudinal 
fasciculus) 
None None 
[120] 
Participants 
with mTBI due 
to auto p 
accidents. 
15 ± 10 days 
post-mTBI 
Decrease 
(various regions) None None 
It can be seen that the study designs and results vary greatly. While these studies suggest 
the information provided by NODDI may be valuable in mTBI, such studies are still 
limited their ability to relate changes in diffusion to the underlying pathological processes 
taking place. Thus, for proper interpretation, we must first evaluate the effect of various 
pathophysiological processes on the signal changes detectable by NODDI in a traumatic 
brain injury. Pre-clinical rodent imaging provides such an opportunity. 
1.6.7 NODDI in Pre-Clinical Rodent Models  
In the development of novel techniques and exploration of disease models, pre-clinical 
animal models are often used. Mice and rats are often the animals of choice in these 
studies, as they share similar genetic information with humans, and in many instances 
similar biochemical, physiological, and microstructural properties [121] in the brain. 
Combined with their fast reproduction rate, relatively low economic footprint, and 
limited variation within breeds, rodent models are ideal to explore many normal and 
disease processes within the nervous system [122]. 
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Although there are advantages to using rodent models, there are also many distinct 
disadvantages in regard to MRI. The largest of these is their size. The rat brain is 
approximately 500 times smaller than the human brain, presenting many technical 
challenges such as limited spatial resolution and low signal-to-noise ratio (SNR) 
[123,124]. Compounding these challenges with those specific to measuring the diffusion 
of water within and near neurites presents a challenging prospect. Many recent technical 
advances in MRI have helped to overcome these challenges including the use of ultrahigh 
field magnetic field strength (of particular importance to this thesis). Additionally, 
advances in modelling and image reconstruction have furthered the abilities of MRI 
within a pre-clinical setting such that the ability to image neurite density directly in-vivo 
in a pre-clinical rodent model is becoming a reality.  
As described in section 1.2, the overall objective of this work is to develop neurite 
orientation dispersion and density imaging into a viable dMRI technique applicable to 
detection of subtle microstructural changes in pre-clinical rodent models of early mild 
traumatic brain injury at 9.4 Tesla. Additionally, we aim to determine whether NODDI 
metrics provided greater sensitivity than standard dMRI metrics to changes in the brain 
following mTBI in a rodent model. However, with any novel technique, the feasibility 
and reproducibility of the underlying metrics must be evaluated, so that researchers can 
confirm or reject a hypothesis with a known level of certainty. Therefore, the objective of 
the first experimental work described in this thesis was to quantify the reproducibility of 
NODDI in a rodent model at 9.4 Tesla. In addition, various analysis techniques and the 
necessary sample sizes and biological effects by which an accurate statistical inference 
may be gained were explored. 
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Chapter 2  
2 Reproducibility of Neurite Orientation Dispersion and Density 
Imaging (NODDI) in Rats at 9.4 Tesla 
2.1 Introduction 
Diffusion weighted magnetic resonance imaging (dMRI) is a powerful magnetic 
resonance modality that provides a wealth of information regarding tissue microstructure, 
from which structural connectivity and pathological changes within the brain can be 
inferred [17,125]. As different microstructures predictably retard diffusion, the apparent 
diffusion of molecules combined with the angle of an applied diffusion gradient provides 
an indirect measure of neuroanatomy [102]. The most commonly used dMRI technique is 
diffusion tensor imaging (DTI). For DTI, a series of pulsed-gradient, spin–echoes are 
used to produce a 3x3 symmetric matrix modelling Gaussian diffusion (3). Most 
commonly, DTI characterizes the overall water diffusion within a given voxel by 
measuring mean diffusivity (MD) and the degree of directionality of the principle 
component of this diffusion, through fractional anisotropy (FA). This technique has been 
utilized for many years and has provided valuable insights into the effects of disease, as 
well as neurological and physiological processes [108,126–129]. 
However, subtle tissue diffusion characteristics may be missed in DTI because the 
method lacks the specificity to identify unique microstructural environments. For 
example, DTI cannot distinguish between distinct processes such as the loss of structural 
integrity and neural remodelling, and as a result provides an inherently vague and limited 
model of neuroanatomy [109,130].  Several more sophisticated dMRI models have been 
developed to overcome the limitations of DTI such as Q-Ball imaging [131], CHARMED 
[27], diffusion kurtosis imaging [132], oscillating gradient diffusion MRI [133], and more 
recently neurite orientation dispersion and density imaging (NODDI) [29]. NODDI 
examines neurite morphology by specifically probing the unique diffusion patterns within 
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three separate microstructural environments: intra-neurite, extra-neurite, and CSF 
compartments [29]. 
Diffusion patterns within the brain may be separated into three distinct microstructural 
environments: highly restricted within neurites (intra neurite compartment), hindered 
diffusion near neurites (extra-neurite compartment) and free diffusion within the CSF 
compartment [30]. A carefully designed diffusion weighting scheme in an MRI pulse 
sequence combined with NODDI modelling is used to produce scalar maps indicating the 
volume fraction contribution of each compartment to the full diffusion signal. The intra-
neurite space is modelled as cylinders of zero radius (modelling highly restricted 
diffusion perpendicular to neurites and free diffusion parallel to neural tracts) dispersed 
according to the Watson distribution (ranging from heavily dispersed to entirely parallel) 
while the extra-neurite space is modelled as Gaussian anisotropic diffusion [134]. Lastly 
the CSF compartment is modelled with Gaussian isotropic diffusion [29].  
The NODDI acquisition incorporates a multi-shell protocol that leads to a multi-
compartmental diffusion MR signal. Previous work has shown that the use of 2 shells 
(each shell corresponding to a subset of diffusion weightings known as b-values) 
combined with several b=0 images, is sufficient to obtain NODDI scalar maps in-vivo 
[29]. These images are reconstructed based on the Stejskal-Tanner equations for a pulsed 
gradient spin-echo (PGSE) experiment, and the total signal determined to be the sum of 
the individual contributions from three non-exchanging tissue compartments (intra-
neurite, extra-neurite, and CSF compartments) [29]. From this signal, quantitative scalar 
image maps may be reconstructed yielding the following NODDI metrics: neurite density 
index (NDI), orientation dispersion index (ODI), and isotropic volume fraction (IsoVF). 
Additionally, by ensuring one shell conforms to DTI acquisition standards (e.g. a single 
shell with > six directions of b = 1000 s/mm2 and one b = 0 volume) [17], it is possible 
within a single scan to obtain standard diffusion tensor metrics such as fractional 
anisotropy (FA) and mean diffusivity (MD). It is commonly recommended that DTI and 
NODDI be acquired simultaneously and analyzed together [109]. While MD and FA are 
routine measures obtained in diffusion imaging, the addition of the ODI, NDI, and IsoVF 
scalar maps can provide a more specific analysis of complex neuroanatomy [109,130]. 
43 
 
ODI characterizes the angular variation and spatial configuration of neurite structures. 
NDI represents the fraction of tissue that comprises axons or dendrites (also referred to as 
intra-neurite volume fraction). Extra-neurite fraction may be reconstructed as 1- NDI, and 
as such does not provide unique information separate from NDI. IsoVF represents the 
CSF water fraction [29].  
Previous use of NODDI has focused largely on the feasibility, reproducibility, and 
application to human imaging at field strengths up to 3 Tesla [135–141]. Specifically, it 
was shown that NODDI metrics were significantly dependent on field strength [142]. 
Many pre-clinical studies use rodent models to study neuro-pathological processes 
requiring extremely small voxel sizes relative to that used in human MRI.  Image signal 
to noise ratio (SNR) is directly proportional to voxel size and to main magnetic field 
strength. Therefore, the use of ultra-high field strengths combined with strong imaging 
gradients helps to achieve adequate SNR for diffusion modelling at the image resolution 
required in rodent models [143]. While the feasibility of NODDI at 9.4 Tesla has been 
shown [144], we are aware of no studies that have explored reproducibility in rodent 
models at 9.4 Tesla. As ultra-high field MRI, and specifically pre-clinical rodent MRI, 
faces many unique challenges such as increased magnetic field inhomogeneities and 
physiological noise [124], it is important to carefully define reproducibility in the context 
of ultra-high field rodent imaging. Thus, our specific objective was to determine the 
reproducibility of the three most commonly derived NODDI metrics (ODI, NDI and 
IsoVF) at 9.4 Tesla in the rat brain. This information is crucial for the planning of future 
studies involving rat models of neurodegenerative disease or neurological injury. 
2.2 Methods 
2.2.1 Subjects  
Ten adult male Sprague Dawley rats were scanned twice on separate days with 7 ± 1 days 
between scans. Sample sizes were chosen to reflect common practice in pre-clinical 
imaging studies. On the day of the scans, anesthesia was initiated by placing the animals 
in an induction chamber with 4-5% isoflurane and an oxygen flow rate of 1-
44 
 
1.5 L/min.  Following induction, isoflurane was maintained between 1.5-2.5% with an 
oxygen flow rate of 1-1.5 L/min through a custom-built nose cone. All animal procedures 
were approved by the University of Western Ontario Animal Use Subcommittee and 
were consistent with guidelines established by the Canadian Council on Animal Care. 
2.2.2 Imaging 
All images were acquired using a 31 cm bore 9.4 Tesla Agilent small animal MRI 
scanner at the Centre for Functional and Metabolic Mapping at the University of Western 
Ontario. Images were acquired with an eight-channel receive coil used in conjunction 
with a 2-channel transmit coil. The receive coil consisted of eight loops adhered to the 
inner surface of a conformal helmet that was adjustable in width to accommodate varying 
head sizes. Low input-impedance preamplifiers were used to reduce inter-element 
coupling. The transmit coil was comprised of two overlapped rectangular loops mounted 
on an inverted U-shaped former. The coil design and optimization followed that built for 
marmoset imaging [145], but with dimensions optimized for rat imaging.  
The NODDI diffusion encoding scheme was incorporated into a centric-ordered spin 
echo echo-planar-imaging (EPI) acquisition pulse sequence (number of shots = 4, number 
of averages = 2, 25 slices with slice thickness = 500 µm, FOV 40 x 40 mm, matrix size 
160 x 160, resulting in-plane resolution = 250 × 250 µm, TE = 25 ms, TR = 5.0 s). Two 
averages were used, rather than increased diffusion directions, to ensure adequate SNR in 
the higher b-value shell for NODDI reconstruction. As it is recommended that NODDI be 
used in conjunction with standard DTI metrics (FA and MD) [109] we chose a b-value of 
1000 s/mm2 for the inner shell. Following the work of Zhang et. al. [29], a second b-value 
of 2000 s/mm2 was chosen. Use of these b-values has been shown to produce 
reproducible values of NODDI specific metrics in human imaging at lower field 
strengths, and can be used to obtain standard DTI measures [29]. To sample q-space, we 
chose a scheme totaling 108 directions spread across two b-values, optimized according 
to Caruyer et. al. [146]. This sampling scheme allows for twice the number of directions 
in the higher b-value shell. Specifically, the outer shell consisted of 72 b-
value = 2000 s/mm2 directions (gradient strength (G) = 339.1 mT/m, time between the 
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start of the first and second diffusion pulse (Δ) = 14.44 ms, the duration of a single 
gradient pulse (δ) = 4.32 ms, TE = 25 ms and TR = 5.0s). The inner shell consisted of 36 
b-value = 1000 s/mm2 directions (G = 169.6 mT/m, Δ = 14.44 ms, δ = 4.32 ms, TE = 25 
ms and TR = 5.0s).  Fifteen b = 0 s/mm2 were interspersed evenly throughout the 
acquisition and two preparation volumes were acquired at the beginning of each average 
but not used, resulting in a total imaging time of 83 minutes. A single reverse phase 
encoded b=0 volume was acquired at the end of the diffusion sequence for subsequent 
use in TOPUP and EDDY (number of shots = 4, number of averages = 2, 25 slices with 
slice thickness = 500 µm, FOV 40 x 40 mm, matrix size 160 x 160, resulting in-plane 
resolution = 250 × 250 µm, TE = 25 ms, TR = 5.0 s). Anatomical images were also 
acquired for each subject within each session using a 3D fast low angle shot [147] pulse 
sequence (250-µm isotropic resolution, FOV 40 x 40 x 20 mm, matrix size = 160 x 160 x 
50, TE = 5.0 ms, TR = 30.0 ms, total acquisition time = 7 min). 
2.2.3 Image Processing 
Images were pre-processed using fMRI Software Library (FSL, v.5.0.10, Oxford, UK). 
TOPUP [148] followed by EDDY [149] was used to correct for eddy current induced 
distortions as well as susceptibility-induced distortions. Brain masks were produced using 
the 3D Pulse Coupled Neural Network (PCNN) tool for Matlab [150]. The NODDI 
Matlab toolbox (available from the UCL Microstructure Imaging Group) was then used 
to produce maps of ODI, NDI, and IsoVF in diffusion space.  
For each subject, the first volume in each diffusion data set (b = 0) was aligned with its 
corresponding anatomical images using a linear registration in FSL (FLIRT) [151]. The 
transformation matrix from the preceding step was then used to bring all NODDI scalar 
maps into anatomical space. Anatomical images were then aligned to the Waxholm Space 
Atlas Sprague Dawley template [152] using a linear transformation (FLIRT) followed by 
a non-linear transformation (FNIRT) [153] in FSL. FNIRT registration parameters were 
optimized for the registration of rodent images. While a quantitative analysis (such as 
Dice coefficient) of registration quality was not performed, anatomical images were 
visually inspected to ensure good registration quality.  The Waxholm Space Atlas 
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Sprague Dawley template includes binary masks for the relevant brain regions of interest 
in this study. Inverse transformation matrices from the preceding steps were used to bring 
these masks from template space into the anatomical image space of each rat. Each mask 
was eroded by 5% around the edges to avoid partial volume effects within a given ROI. 
2.2.4 Statistical Analysis 
Statistical analyses to examine measurement reproducibility were performed for the mean 
region of interest (ROI) analysis, the whole brain voxel-wise analysis, and the voxel-wise 
analysis within a given ROI. These three techniques were chosen as they represent the 
most common analysis techniques in neuroimaging studies. The ROI analysis focused on 
six different tissue regions: thalamus, corpus callosum, dentate gyrus, hippocampus, 
whole brain white matter, and whole brain grey matter.  In both the ROI and voxel-wise 
analyses the scan-rescan reproducibility was characterized using the coefficient of 
variation (CV). CV was chosen as it reflects both the reproducibility and variability of 
these metrics as well as provides insight into necessary sample sizes and minimum 
detectable effect size. CVs were calculated between subjects and within subjects to 
quantify the between subject reproducibility and within subject reproducibility 
respectively. The between subject CV was calculated separately for the scan and rescan 
conditions as the group standard deviation divided by the mean values from subjects 1-8. 
These two CV values were then averaged for the mean between subject’s CV in each 
case. The within subject CV was calculated as the standard deviation of the two scans 
divided by the mean value. The 8 within subjects CVs were then averaged to determine 
the mean within subject CV. Furthermore, the between subject CV was used to determine 
the minimum number of subjects needed per group to detect a defined biological effect. 
Similarly, the within subject CV was used to calculate the minimum detectable biological 
effect with a given number of subjects per group. The details of these calculations follow 
those presented in van Belle [154]. The minimum number of subjects and minimum 
detectable biological effect were both determined at a 95% significance level (𝛼 = 0.05) 
and power of 80% (1 − 𝛽 = 0.80). 
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2.3 Results 
The minimum accepted average whole-brain SNR was 25 at b=0 for each of the included 
data sets. Two data sets were removed from the analysis due to low SNR causing 
significant reconstruction bias. Therefore, data were successfully acquired and analyzed 
from eight subjects (age 102 ± 13 days at time of initial scan, weight 323 ± 37 g) at two 
separate time points. For each subject the re-scan time point was between six and eight 
days after the original scan. The time of day was not standardized for the scans. Figure 
2.1 shows representative cross sections of raw diffusion data (b=0) from a single subject, 
as well as scalar maps of ODI, NDI, and IsoVF.   
 
Figure 2.1 - Representative in-plane cross sections from a single subject showing 
unprocessed raw diffusion image data (4 shot, centric ordered, 2 averages, 25 coronal 
slices with slice thickness = 500 µm, 250 × 250 µm in plane resolution, FOV 40 x 40 
mm, matrix size = 160 x 160, TE = 25 ms, TR = 5.0 s), and corresponding scalar image 
maps of the following NODDI values: Orientation Dispersion Index (ODI), Neurite 
Density Index (NDI), and Isotropic Volume Fraction (IsoVF).   
2.3.1 ROI Analysis  
Similar to previous human and rodent studies, higher average ODI values were observed 
within grey matter regions compared to that of white matter regions (Figure 2.2) as 
expected because neurite orientation is more widely dispersed throughout grey matter 
[142,144]. NDI and IsoVF values were similar between white and grey matter. Mean 
between and within subject CV for ODI ranged from 4.0-9.2% within all ROIs, NDI 
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ranged from 1.9-11.3%, while IsoVF ranged from 9.0-48.6% (Figure 2.3). In general, for 
each metric within a given ROI the mean between subject CV was higher than the within 
subject CV. 
 
Figure 2.2 – Region of interest (ROI) values for ODI, NDI and IsoVF in both the scan 
and rescan conditions for several representative brain regions. Each box represents the 
range from 25th to 75th percentile (Interquartile Range) with the median depicted by the 
line within the box.  
 
Figure 2.3 - Mean coefficient of variation (CV) for each ROI. Values for the between 
subject condition represent the mean ± standard deviation within each ROI averaged 
over a scan-rescan protocol. Values for the within subject condition represent the mean ± 
standard deviation within each ROI averaged over the eight subjects. 
2.3.2 Whole brain voxel-wise analysis  
The whole brain voxel-wise analysis showed a similar trend to the ROI analysis in terms 
of CVs. In the between subject histogram, over 90% of voxels fell below a CV of 20% 
for ODI while in the within subject histogram 90% of voxels fell below a CV of 17% 
(Figure 2.4 and Figure 2.5). For NDI over 90% of voxels fell below a CV of 15% and 
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12% for the between and within subject histograms respectively. The CV for IsoVF, 
ranged well above 100% for many voxels for both histograms.  
 
Figure 2.4 – Whole brain average between subject CV maps and histogram. Values for 
the between subject condition represent the mean CV within each voxel for the scan and 
rescan conditions averaged over the two scans. The resulting histogram has been 
extracted from the averaged scans. Heat maps from a representative slice show the 
regional variation for each metric. 
 
Figure 2.5 - Whole brain average within subject CV maps and histogram. Values for the 
within subject condition represent the mean CV within each voxel for each subject 
averaged over all eight subjects. The resulting histogram has been extracted from the 
averaged scans. Heat maps from a representative slice show the regional variation for 
each metric. 
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2.3.3 Voxel-wise ROI analysis 
The voxel-wise approach targeted to specific ROIs (Figure 2.6) reinforced the results 
observed in mean ROI and the voxel-wise approaches. For ODI, over 90% of voxels fell 
below a CV of 18% in the between subject histogram, and 12% in the within subject 
histogram for all ROIs. For NDI, over 90% of voxels fell below a CV of 10% in the 
between subject histogram and 8% in the within subject histogram for all ROIs. The CV 
for IsoVF once again ranged well above 100% for many voxels in all ROIs. In all cases, 
dispersion of CV values increased with increasing ROI sizes. Likewise, in all cases and 
all ROIs the CVs and dispersion of CV values were lower within subjects compared to 
between subjects.  
 
Figure 2.6  – Voxel-wise between and within subject CV histograms within each 
representative ROI. Voxel-wise values for the between subject condition represents the 
mean CV within each ROI for both the scan and rescan conditions averaged over the two 
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scans. Voxel-wise values for the within subject condition represent the mean CV within 
each ROI averaged over the eight subjects. 
2.3.4 Sample sizes and minimum detectable effect 
Using the between subject whole brain voxel-wise CVs, the minimum number of subjects 
was determined on a voxel-by-voxel basis that would allow detection of a statistically 
significant change of 5%, 10%, 15% and 20% between subjects in each metric. ODI 
produced detectable changes on the order 10% in all voxels for moderate sample sizes (n 
< 10) but required large sample sizes (n > 10) for whole brain voxel-wise detection of 
changes on the order of 5% (Figure 2.7). NDI was able to detect changes on the order of 
5% in all voxels with small sample sizes (n < 6 for all voxels).  IsoVF required large 
sample sizes (n > 10) to detect changes of any magnitude on a voxel-wise basis.  
Using the within subject whole brain voxel-wise CVs, the minimum statistically 
significant change that may be detected in each metric on a voxel-wise basis was 
determined using a scan re-scan protocol for sample sizes of 6, 8 and 10 within each 
group. For over 90% of voxels, ODI was also able to detect small changes (<10%) on a 
scan-rescan basis with all sample sizes discussed, NDI showed detection of very small 
changes (<5%) with all sample sizes discussed and IsoVF lacked the ability to detect 
significant changes at any samples size explored. 
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Figure 2.7 – Whole brain voxel-wise histograms representing the i) number of subjects 
necessary to detect a statistically significant effect with a change in the given metric of 
5%, 10%, 15% and 20% and ii) the minimum detectable effect with each metric under a 
scan-rescan study design given group sample sizes of 6, 8 and 10. Note the varied scales 
for the IsoVF metric in each category as opposed to the ODI and NDI metrics. 
2.4 Discussion 
This study examined the reproducibility of the three most commonly derived NODDI 
metrics (ODI, NDI, and IsoVF) in the rodent brain at 9.4 Tesla.  ODI and NDI were 
reproducible, showing low coefficients of variation in both the between and within 
subject conditions. CVs were lower within subjects compared to between subjects, 
indicating less variability on a within subject scan-rescan basis, as expected. These trends 
were observed in the mean ROI, whole brain voxel-wise, and targeted voxel-wise 
analyses.  
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Using the whole brain coefficients of variation on a voxel-by-voxel basis it was possible 
to detect changes on the order of 10% and 5% respectively in ODI and NDI metrics with 
feasible study samples sizes.  For ODI, over 90% of voxels showed the ability to detect a 
10% or greater change with sample sizes of five or more, while NDI showed the ability to 
detect a change of 5% or greater with sample sizes of five or more. NDI was the most 
sensitive in all cases, followed by ODI. Furthermore, it was shown that using a scan-
rescan protocol and standard sample sizes (6, 8, and 10) it was possible to detect very 
small changes for both ODI and NDI. For example, sample sizes of eight per group 
(common to many preclinical studies) allowed biological effects as small as 5% to be 
detected on a voxel by voxel basis for both metrics.  
While ODI and NDI were shown to be reproducible metrics, IsoVF was not. This was 
shown previously in similar studies of the human brain [142]. The IsoVF metric suffers 
from not only low values intrinsically in the given context but is also highly susceptible 
to noise [142]. This combination led to high average CVs (> 20%) in all measures 
explored in this study. Consequently, with the scan parameters used in this study, the 
reproducibility of IsoVF is limited. Improvements in SNR could increase the 
reproducibility of IsoVF but would come at the cost of increased scan time, decreased 
image resolution, or decreased angular resolution. It should be noted that inaccurate 
estimates of IsoVF could slightly bias the absolute values of NDI at low SNR, however 
this bias is expected to be consistent across all subjects and scans, allowing meaningful 
comparisons to be made under consistent scan parameters. As of now the optimal angular 
and image resolution in a rodent model of NODDI has yet to be explored, and it must be 
assumed that higher resolution in both improves the quality of the resulting scalar metric 
maps. Thus, an increase in scan time would be necessary. As the scan time in the present 
study was already high (83 minutes) it may be that the necessary scan time to improve the 
quality of IsoVF scalar maps is not feasible or cost effective.  
These findings are consistent with previous research using human subjects. In humans, 
NODDI has been shown to produce accurate and reproducible metrics of ODI and NDI 
both between and within subjects [142]. The magnitude of NDI, ODI, and IsoVF have 
been shown to vary at different field strengths [142], and thus it is important to 
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characterize these metrics not only in new animal models, but also at each field strength 
used. At the time of writing we are not aware of any other studies that specifically look at 
the reproducibility of NODDI in an in-vivo rodent model. This study shows NODDI to be 
reproducible in a rodent model at 9.4 Tesla and that this technique has the potential to 
detect very subtle tissue microstructure changes in a rodent model.  
There are several limitations that should be considered in this study.  Registration was 
performed using FLIRT [151] and FNIRT [153] in FSL. The quality of these registrations 
was not specifically quantified in terms of similarity overlap. As the quality of 
registration is important to both ROI and voxel-wise analyses, future studies may benefit 
from improvements and optimization of the registration process. Specifically, when using 
a targeted voxel-wise approach within a given ROI, registration can be optimized within 
that region, thereby increasing the precision of the analysis. Currently, the optimal 
angular resolution, image resolution and b-value combination in our NODDI pulse 
sequence has not been fully explored in a rodent model at 9.4 Tesla. It is possible that at 
high angular resolution more subtle changes in orientation are detected, and at higher 
image resolution more subtle changes in neurite microstructure may be shown. 
Furthermore, these parameters may vary greatly in coherently ordered white matter 
compared to less ordered structures within regions of grey matter and may be altered in 
disease states. These considerations must be balanced against scan time for any in-vivo 
study. Further exploration of optimal angular resolution sampling schemes and image 
resolution would lend strength to this technique and lead to a more robust acquisition and 
analysis pipeline. Additionally, the optimal b-value has not been expressly explored in 
rodents at 9.4 Tesla. In humans, the optimal b-values were explored through simulation 
and in-vivo study, and it was found that as long as two shells with moderate b-value were 
used, the precise choice of b-value made minimal difference [29]. Finally, it should be 
noted that for the within-subject calculation of CV, the standard deviation was 
determined from only two data points. As a result, this this standard deviation may not 
accurately represent the spread of data within the population, leading to an unknown bias 
in the resulting CV. 
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The current study was designed to evaluate reproducibility of the NODDI metrics over a 
one-week interval, as this interval is relevant for many time course studies. While subtle 
changes in brain plasticity were of some concern, the results show that over this interval 
the ODI and NDI metrics were reproducible. Finally, we know of no studies which have 
expressly attempted to produce a template of absolute values of NODDI metrics within 
various brain regions of rodents at 9.4 Tesla. While intrinsic variability will always be 
present in these values due to scan parameters, it would be useful to attempt this 
characterization for all brain regions.  
Preclinical imaging techniques, and specifically diffusion imaging techniques, are 
designed to detect very subtle changes in disease models, which may not be seen with 
anatomical based imaging techniques. The potential to improve the ability to detect these 
very small changes through novel neuroimaging techniques, such as NODDI, could 
illuminate early events in disease processes such as neurodegeneration. Early detection of 
key pathways and mechanisms involved in the progression of these devastating diseases 
may lead to a more thorough understanding of the downstream biological effects. By 
showing NODDI metrics to be reproducible in a rodent model at ultra-high field 
strengths, we may now apply this technique to appropriate pre-clinical models, in an 
effort to further our understanding of complex diseases processes affecting 
neuroanatomy. 
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Chapter 3  
3 Neurite Orientation Dispersion and Density Imaging (NODDI) 
in a Rodent Model of Early Mild Traumatic Brain Injury 
3.1 Introduction 
Mild traumatic brain injury (mTBI) is known to result in a range of metabolic, 
microstructural, and behavioral effects. The clinical presentation varies greatly and 
sometimes unpredictably between subjects and over time and may impair many physical 
and cognitive functions [155–158]. Currently there is no pathognomonic test that can be 
used to accurately diagnose mTBI, assess the severity, or predict and monitor long-term 
outcome. Clinical assessments often rely on subjective measures and patient self-
reporting, which are potentially biased, and may limit their utility [45,46]. Furthermore, 
Clinical Practice Guidelines (CPGs) regarding appropriate diagnosis and care following a 
traumatic brain injury vary widely in quality, comprehensiveness, and implementation 
[159–161]. Thus, it is imperative to develop unbiased metrics of mTBI that will allow 
informed and accurate diagnosis and lead to more effective patient treatment.  
Very little is currently known about changes in the brain within the extremely early 
period post mTBI (< 4 hours post-injury). Patients are almost never available during this 
early phase for rigorous testing or data collection and thus little MRI data is available for 
this initial stage of injury [162]. Often, the severity of the injury is underreported, with 
patients only being admitted or cared for if symptoms worsen, once again eliminating the 
possibility to obtain clinical data in the very early stages of mTBI [163–165]. However, it 
is critical to understand the immediate underlying neurostructural changes that occur in 
the brain following injury to place observations at later time points into proper context. It 
is has been previously shown that many microstructural and neuroinflammatory changes 
occur in mTBI including neuronal cell death, axonal beading, and neuroinflammatory 
processes, but these studies have been largely limited to ex-vivo analysis [48,166–169]. 
Furthermore, several of these studies have indicated that many of these processes can 
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occur as early as 30 minutes post-injury, although there is substantial heterogeneity in the 
timing, injury model, and animal model used for these studies [56,170–173]. It remains 
imperative to develop methods to accurately and reliably assess and monitor the 
immediate microstructural and neuroinflammatory processes that occur following mTBI. 
Diffusion-weighted MRI (dMRI) is known to be highly sensitive to probing such changes 
in brain microstructure and neuroinflammatory processes in-vivo (please refer to 
Hutchinson et. al. [174] for an in depth review). 
A number of different diffusion MRI approaches may be applied to the study of mTBI, 
however neurite orientation dispersion and density imaging (NODDI) provides the most 
direct means of assessing neurite integrity. NODDI is a powerful diffusion-weighted 
magnetic resonance imaging (dMRI) modality that can probe anatomical microstructure 
directly within the brain through careful measurement of water diffusion parameters [29]. 
NODDI uses a biophysical model by which the total dMRI signal is attributed to the 
intra-neurite, extra-neurite and CSF compartments. Each tissue compartment has unique 
diffusion characteristics and thus the fraction of signal attributed to each compartment 
may be separated and recovered uniquely. In this two-level compartmentalization 
approach, the volume fraction of water that diffuses freely (ie. Gaussian diffusion) is 
attributed to the CSF space and separated from the total signal. The remaining signal is 
compartmentalized into volume fractions of the intra-neurite space, where diffusion is 
highly restricted and directional, and the extra-neurite space, where Gaussian diffusion is 
hindered. The volume fraction of the intra-neurite space is represented by the metric 
neurite density index (NDI) and represents the volume fraction of signal originating from 
the dendrites and axons. The signal emanating from the extra-neurite space is 
representative of diffusion within cell bodies and near neurons and is simply 1- NDI. 
Thus, changes in the volume fraction of water in the intra-neurite and extra-neurite space 
are dependent on one another and will vary inversely. In addition to NDI, NODDI 
provides an orientation dispersion index (ODI), which characterizes the spatial 
configuration of neurites on a range from 0-1, with values near 1 indicating high 
dispersion (eg. grey matter), and values near 0 indicating highly coherent organization 
(eg. white matter). In addition, using data from the same acquisition it is possible to 
obtain the common diffusion tensor imaging (DTI) metrics, such as fractional anisotropy 
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(FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD). FA 
represents the degree of directionality (as a scalar value from 0-1) and MD represent the 
overall amount of diffusion of the diffusion tensor as a whole. AD represents the amount 
of diffusion along the primary eigenvector alone and RD represents the average amount 
of diffusion along the secondary and tertiary eigenvectors [17].  
There have been extensive studies using DTI in both people and pre-clinical animal 
models of mTBI, but the results have varied largely and provide little information with 
regard to the immediate structural and physiological responses in the brain to this injury 
[103]. Previous studies applying NODDI specifically to mTBI have occurred exclusively 
in the clinical setting. Churchill et. al. showed an elevated NDI and reduced ODI in 
various regions such as the corona radiata and corpus callosum of athletes with a previous 
history of concussion (but no reported concussions within 6 months) compared to 
controls [118]. In a further study, Churchill et. al. showed that in athletes scanned within 
7 days of a diagnosed concussion, NDI was reduced in regions such as the corona radiata 
and longitudinal fasciculus, and that these changes persisted beyond the time that athletes 
were cleared to return to play [175]. While these studies are informative in clinical 
settings, there are currently no studies, either clinical or pre-clinical, that have applied 
NODDI to measure microstructural changes during the first few hours following mTBI.  
Similarly, we are unaware of any studies using any dMRI technique to examine changes 
as early as 1-hour post-injury in a mTBI model. However, in a recent study of mTBI in 
rats, mild to moderate changes in group mean FA, MD, and RD were detectable in the 
genu of the corpus callosum at 4 hours post-injury (and later timepoints) [176]. In another 
study of traumatic axonal injury (TAI) in mice, it was shown that statistically significant 
changes in AD, and relative anisotropy (RA) were detected in the corpus callosum by 4-6 
hours following injury [21]. While the TAI injury model is far more severe than mTBI, 
taken together these studies indicate the presence of microstructural changes detectable 
with dMRI as early as 4 hours post-injury.   
Given the lack of information regarding immediate brain microstructure changes 
following mTBI, the purpose of the current study was to apply NODDI to a rodent model 
of mTBI to determine whether microstructural changes in the corpus callosum could be 
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detected immediately following injury. Furthermore we investigated potential changes in 
the hippocampus as this brain region has been implicated in neurophysiological changes 
after various brain injuries [177,178].  Finally, we compared NODDI metrics to standard 
DTI metrics to determine if NODDI provided greater sensitivity to early microstructural 
changes following mTBI. 
3.2 Methods 
3.2.1 Subjects 
Fifteen adult male Wistar rats (injury: n = 9, age at baseline scan: 123 ± 26 days, weight 
at baseline scan: 392 ± 27 g, control: n = 6, age at baseline scan: 131 ± 22 days, weight at 
baseline scan: 380 ± 17 g) were acquired from Charles River. Each animal was randomly 
assigned to either the control or injury group and was scanned twice: 7 days prior to 
injury (Timepoint 1), and from 1 – 4 hours post closed skull controlled cortical impact. 
From hours 1-4 post injury, data was collected approximately every 1 hour giving 3 
acquisitions sequentially (Timepoints 2 - 4). Please refer to Figure 3.1 for the timeline of 
acquisition. All animal procedures were approved by the University of Western Ontario 
Animal Use Subcommittee and were consistent with guidelines established by the 
Canadian Council on Animal Care. 
 
Figure 3.1 – Timeline of data acquisition for animals randomly assigned to the injury 
group which received a single closed skull controlled cortical impact.  
3.2.2 Injury 
While many different models have been developed to study TBI and mTBI in the pre-
clinical setting, such as the Fluid Percussion Injury (FPI) [179,180] model, the Closed-
Head Impact Model of Engineered Rotational Acceleration [181],  and Blast TBI model 
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[182–184], we chose to use the closed skull controlled cortical impact (CCI) model [185–
188]. CCI is a common and well documented model suited to closed skull mTBI, due to 
its close control, reproducibility, and pathophysiological response spectrum that mimics 
many important features of mTBI observed in humans [189–192]. It has been well 
documented in several animal models including rats and mice [193]. Since it is 
advantageous from an imaging perspective to use a larger brain, rats were used for the 
current study and the injury model was consistent with previous studies that have used 
closed skull controlled cortical impact to induce a mTBI [193–198].   
Animals were anaesthetized by induction with 4% isoflurane followed by maintenance 
with 2% isoflurane. Each animal was placed in a Kopf mouse anesthesia mask (David 
Kopf Instruments, LLC, USA) under a traumatic brain injury device (TBI 0310, Precision 
Systems and Instrumentation, LLC, USA). For each impact, the device was programmed 
to impact at an intended depth of 3.0 mm, a velocity of 3.5 m/s and a 500-millisecond 
dwell time. The impact region for each animal was shaved prior to impact. Each animal 
received a single closed skull controlled cortical impact, centered at the sagittal suture, 
with a custom-made, 7 mm-diameter, pliant, silicone tip. Following controlled cortical 
impact, anesthesia was maintained at 2% isoflurane and using an in-house built portable 
induction chamber, each animal was transferred to the small animal MRI facility. Control 
animals were anaesthetized 20 minutes prior to their MRI to match the anesthesia time 
between induction and scan initiation in impacted animals. 
3.2.3 Image Acquisition 
Images were acquired using a 9.4T Bruker small animal MRI scanner at the Centre for 
Functional and Metabolic Mapping located within the Robarts Research Institute at the 
University of Western Ontario. Imaging included the acquisition of high-resolution 
anatomical images and NODDI in all animals.  Anatomical images were acquired for 
each subject at the beginning of each session using a T2-weighted TurboRARE pulse 
sequence (8 averages, 32 slices, slice thickness = 500 µm, FOV 32 x 32 mm, matrix size 
160 x 160, in-plane resolution = 200 x 200 µm, TE = 44 ms, TR = 7s, echo spacing = 11 
ms, rare factor 8, total acquisition time = 14 min)[199].  The NODDI diffusion sequence 
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was incorporated into a multi-shot, spin echo, echo-planar-imaging (EPI) acquisition 
pulse sequence (4 shots, 32 slices, slice thickness = 500 µm, FOV 40 x 40 mm, matrix 
size 160 x 160,  in-plane resolution = 250 × 250 µm, TE = 26.71 ms, TR = 2.5 s). 
The NODDI diffusion scheme used was previously described in detail and was shown to 
produce reproducible and reliable results at 9.4 Tesla [200]. Briefly, a q-space sampling 
scheme was used across two-shells, optimized according to Caruyer et. al. [146], with a 
total of 90 directions.  In shell one, 30 directions with b-value = 1000 s/mm2 were 
obtained using the following diffusion gradient parameters: gradient strength 
(G) = 172.85 mT/m, time between the start of the first and second diffusion pulse 
(Δ) = 14 ms, the duration of a single gradient pulse (δ) = 4.5 ms.  In shell two, 60 
directions with b-value = 2000 s/mm2 were obtained using the following diffusion 
gradient parameters: gradient strength (G) = 345.70 mT/m, time between the start of the 
first and second diffusion pulse (Δ) = 14 ms, the duration of a single gradient pulse 
(δ) = 4.5 ms.   Ten b = 0 s/mm2 scans were interspersed evenly throughout the 
acquisition. Four averages were used to ensure adequate signal to noise ratio (SNR) in the 
higher b-value shell. The imaging time for each acquisition (four averages) was 66 
minutes 36 seconds. A single reverse phase encoded b=0 volume was also acquired prior 
to the diffusion sequence for subsequent use in image processing to correct image 
distortions.  
3.2.4 Image Processing 
Brain masks were produced using the 3D Pulse Coupled Neural Network (PCNN) tool 
for MATLAB (R2019a) [150]. Raw data were pre-processed using fMRI Software 
Library (FSL, v. 6.0.1, Oxford, UK). TOPUP [148] followed by EDDY [149] was used to 
correct for eddy current induced distortions as well as susceptibility-induced distortions. 
The FDT toolbox (v. 5.0) was used to produce maps of FA, MD, AD, and RD. The 
NODDI Matlab toolbox (available from the University College London (UCL) 
Microstructure Imaging Group) was then used to produce maps of NDI, ODI, and IsoVF. 
All diffusion maps were produced within each subject’s native diffusion image space. 
While IsoVF is produced during the processing steps, our previous work has indicated it 
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has extremely high variability and low reproducibility with this scan protocol and 
therefore we limited our analysis to NDI and ODI only. 
3.2.5 Image Registration 
For each subject, the first volume in each diffusion data set (b = 0) was aligned with its 
corresponding anatomical images using a linear registration in FSL (FLIRT) [151]. The 
anatomical image for each subject was then aligned to the Waxholm Space Atlas Sprague 
Dawley template [152] using a linear transformation (FLIRT) followed by a non-linear 
transformation (FNIRT) [153] in FSL. Binary ROI masks of the corpus collosum and 
hippocampus from the Waxholm Space Atlas, were then transformed into the anatomical 
space of each individual subject by inverting the preceding non-linear transformations. 
Finally, the masks were brought into diffusion space using the inverse transformation 
matrix from the b0 image to anatomical image registration. Thus, each mask was brought 
into each subject’s individual native diffusion image space. Each mask was then eroded 
by a single voxel around the edges to avoid partial volume effects. Masks were visually 
inspected to ensure accuracy. For a full description of the processing steps please and 
representative binary ROI masks please refer to Supplement. 
3.2.6 Statistical Analysis  
For each subject, at each timepoint the mean value of each individual scalar metric within 
each relevant ROI was extracted using fslstats and the relevant binary mask. A mixed 
ANOVA in SPSS [201] was used for each metric to determine if there were statistically 
significant interaction effects (p < .05) between controls and injured animals over time.  
This test examined whether each metric changed over time and whether those changes 
were different between the two groups. Mauchly’s Test was used to determine if the 
assumptions of sphericity were violated. In cases where the assumption of sphericity was 
rejected, the Greenhouse-Geisser correction was used. In each case where a statistically 
significant interaction effect occurred, a follow-up repeated measures ANOVA was run 
separately on each group (injured and controlled) to determine if there were statistically 
significant changes (p < .05) in the diffusion metric over time within each group. 
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Furthermore, post-hoc analysis was used to determine which timepoints differed within 
each group (Bonferroni corrected).  
3.3 Results 
Imaging data were successfully acquired from all 15 animals. Figure 3.2 provides 
representative anatomical and corresponding NODDI and DTI scalar maps in a single 
animal.  
 
Figure 3.2 – Representative axial single-subject A) raw diffusion image data (b0) and the 
following scalar diffusion maps: B) Neurite Density Index (NDI) C) Orientation 
Dispersion Index (ODI) D) Isotropic Volume Fraction (IsoVF) E) Fractional Anisotropy 
(FA) F) Mean Diffusivity (MD) G) Axial Diffusivity H) Radial Diffusivity . The diffusion 
images were acquired with a multi-shell  sequence (10 b= 0 s/mm2, 30 b = 1000 s/mm2 
and 60 b= 2000 s/mm2) incorporated into a multi-shot, spin echo, echo-planar-imaging 
(EPI) acquisition pulse sequence (4 shots, 32 slices, slice thickness = 500 µm, FOV 40 x 
40 mm, matrix size 160 x 160, in-plane resolution = 250 × 250 µm, TE = 26.71 ms, TR = 
2.5 s). 
The exact start and end time of each image varied slightly for each animal: Timepoint 1 
(or baseline scan) obtained 7 days prior to injury, Timepoint 2 began at 75 minutes  ± 16 
minutes post-injury, Timepoint 3 began at 142 ± 17 minutes post-injury, and Timepoint 4 
began at 210 ± 17 minutes post-injury.  
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3.3.1 Corpus Callosum 
Mean ROI metrics in the corpus callosum (Figure 3.3) show a significant increase in the 
NDI and ODI immediately after injury that persists to four hours post injury.  The first 
timepoint after injury showed a 0.046 ± 0.026 (7.83%) increase in average NDI and a 
0.051 ± 0.037 (13.7%) increase in average ODI compared to baseline. In contrast, no 
changes were observed over time in the control groups.  Relevant statistical results are 
described in Table 3.1. 
 
Figure 3.3 - Mean ROI Metrics within the corpus callosum for injured and control 
subjects. At each point the mean of the ROI values ± SEM is shown. For NDI and ODI in 
the corpus callosum a mixed effects ANOVA in SPSS showed a statistically significant 
group by time interaction (p < .05). A repeated measures ANOVA was then used to 
determine individual differences amongst the injured and control groups. Post-hoc 
pairwise comparisons (Bonferroni corrected) were performed between individual 
timepoints within each group. Statistically significant (p < .05) pairwise differences are 
indicated by *. Statistical results are listed in Table 3.1 (Mixed ANOVA) and Table 3.2 
(Repeated Measures ANOVA). 
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Table 3.1 lists the statistical results of the mixed effects ANOVA for both NODDI and 
DTI metrics in the corpus callosum. There was a statistically significant (p < .05) group 
by time interaction effect for NDI and ODI. There were no statistically significant 
interaction effects (p > .05) of group by time for FA, MD, AD and RD. 
Table 3.1 – Statistical results of the mixed effects ANOVA for NODDI and DTI metrics 
within the corpus callosum. Statistical significance is taken to be p < .05, is denoted with 
an asterisk (*) and indicates there is a statistically significant group by time interaction 
for that metric within the corpus callosum.  
Metric Statistical Results   
NDI F (3,39) = 6.573 p = .001* Sphericity Assumed 
ODI F (3,39) = 6.355 p = .011* Greenhouse-Geisser 
FA F (3,39) = 0.445 p = .722 Sphericity Assumed 
MD F (3,39) = 1.085 p = .345 Greenhouse-Geisser 
AD F (3,39) = 0.166 p = .772 Greenhouse-Geisser 
RD F (3,39) = 1.919 p = .142 Sphericity Assumed 
The follow-up univariate analysis of NDI and ODI showed a statistically significant 
change over time for the injured group, while no statistically significant change over time 
occurred within the control group for these metrics Table 3.2. Statistically significant 
changes between individual timepoints within the injury group are depicted in Figure 3.3. 
It should be further noted that for every individual subject in the injury group, an increase 
occurred in both NDI and ODI from timepoint 1 (Baseline) to timepoint 2 (refer to Figure 
3.4). Following this increase, a more heterogenous individual response occurred from 
timepoints 2-4, but statistically significant group increases were observed at all three 
timepoints post impact. 
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Table 3.2 - Statistical results of the follow up univariate ANOVA for NDI and ODI 
metrics within the corpus callosum. Statistical significance is taken to be p < .05, is 
denoted with an asterisk (*) and indicates there is a statistically significant change in 
each metric over time within the given group (Injured or Control).  
Metric Statistical Results 
NDI Injured F (3,21) = 13.618 p = .001 Greenhouse-Geisser 
Control F (3,9) = 1.318 p = .328 Sphericity Assumed 
ODI Injured F (3,21) = 9.504 p = .000 Sphericity Assumed 
Control F (3,9) = 3.431 p = .066 Sphericity Assumed 
 
Figure 3.4 - Mean ROI values of NDI and ODI within the corpus callosum for the injured 
group only. It can be seen that for every individual subject in the injured group, a 
statistically significant increase in both NDI and ODI occurred from timepoint 1 to 
timepoint 2. Following this increase, statistically significant group increases were 
observed at all three timepoints post impact, but the individual response varied. 
Statistical significance is taken to be p < .05, is denoted with an asterisk (*). 
3.3.2 Hippocampus 
Mean ROI metrics in the hippocampus (Figure 3.5) show a significant increase in the 
NDI only immediately after injury that persists to four hours post injury. The first 
timepoint after injury showed a 0.022 ± 0.021 (3.93%) increase in average NDI. In 
contrast, no changes were observed over time in the control groups. Relevant statistical 
results are described in Table 3.3. 
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Figure 3.5 - Mean ROI metrics within the hippocampus for injured and control subjects. 
At each point the mean of the ROI values ± SEM is shown. For NDI and ODI in the 
corpus callosum a mixed effects ANOVA in SPSS showed a statistically significant group 
by time interaction (p < .05). A repeated measures ANOVA was then used to determine 
individual differences amongst the injured and control groups. Post-hoc pairwise 
comparisons (Bonferroni corrected) were performed between individual timepoints 
within each group. Statistically significant (p < .05) pairwise differences are indicated  
by *. Statistical results are listed in Table 3.3 (Mixed ANOVA). 
Table 3.3 lists the statistical results of the mixed effects ANOVA for both NODDI and 
DTI metrics in the hippocampus. There was a statistically significant (p < .05) group by 
time interaction effect for NDI only. There were no statistically significant interaction 
effects (p > .05) of group by time for ODI, FA, MD, AD and RD. 
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Table 3.3 - Statistical results of the mixed effects ANOVA for NODDI and DTI metrics 
within the hippocampus. Statistical significance is taken to be p < .05, is denoted with a 
(*) and indicates there is a statistically significant group by time interaction for that 
metric within the hippocampus.  
Metric Statistical Results 
NDI F (3,39) = 7.077 p = .009 Greenhouse-Geisser 
ODI F (3,39) = 0.943 p = .382 Greenhouse-Geisser 
FA F (3,39) = 0.086 p = .967 Sphericity Assumed 
MD F (3,39) = 0.275 p = .843 Greenhouse-Geisser 
AD F (3,39) = 0.656 p = .493 Greenhouse-Geisser 
RD F (3,39) = 0.186 p = .779 Greenhouse-Geisser 
The follow-up univariate analysis of NDI showed a statistically significant change over 
time for the injured group while no statistically significant change over time occurred 
within the control group [Injured F(3,24) = 8.648, p = .000 Greenhouse-Geisser; Control 
F(3,15) = 2.015, p = .155, Sphericity Assumed]. Statistically significant changes between 
individual timepoints within the injury group are depicted in Figure 3.6. Once again, we 
see an increase in NDI from timepoint 1 (Baseline) to timepoint 2 in each individual 
subject. Following this increase, a more heterogenous individual response occurred from 
timepoints 2-4, but statistically significant group increases were observed at all three 
timepoints post impact compared to baseline. 
 
Figure 3.6 – Mean ROI values of NDI and ODI within the hippocampus for the injured 
group only. It can be seen that for every individual subject in the injured group, a 
statistically significant increase in both NDI and ODI occurred from timepoint 1 to 
timepoint 2. Following this increase, statistically significant group increases were 
observed at all three timepoints post impact, but the individual response varied. 
Statistical significance is taken to be p < .05, is denoted with an asterisk (*). 
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3.4 Discussion 
The current study used an adult rodent model to examine the immediate effects of mild 
TBI on changes in conventional diffusion MRI and NODDI metrics. While no changes in 
traditional DTI metrics (FA, MD, AD and RD) were detected within the first four hours 
of injury, significant differences were observed in the NODDI metrics (NDI and ODI) as 
early as 1-hour post injury compared to baseline suggesting a microstructural change in 
this rodent model.  Specifically, both NDI and ODI were increased in the corpus 
callosum immediately after impact, and NDI was increased in the hippocampus.  
Therefore, this study provides evidence that NODDI metrics are sensitive to 
microstructural changes within the earliest stages of this rodent model of mild traumatic 
brain injury, and that these NODDI metrics are more sensitive to such changes than 
traditional DTI metrics.  
Neurite density index (NDI) represents the volume fraction of signal originating from the 
dendrites and axons.  In the current study, NDI was shown to be elevated in both the 
corpus callosum and hippocampus at the first timepoint post-injury when compared to 
baseline values in the mTBI group and continued to increase over time.  Several 
microstructural changes should be considered to explain these observations including the 
many microstructural changes that have been previously shown in models of mTBI 
including neuronal cell death, axonal swelling and beading, and various myelination and 
remyelination processes [47,48,202]. Due to the extremely early measurement time used 
in the current study (~1h post injury), the most likely of these processes that could be 
occurring and contributing to the increased NDI is axonal swelling and beading. Previous 
studies have indicated the presence of axonal swelling and beading in mTBI, with some 
models showing this phenomenon as early as 30 minutes to 1 hour post injury [203,204], 
although there is substantial heterogeneity in both the injury and animal model used in 
many of these studies [56,170,171]. In the current study, the observed increase in NDI is 
consistent with an increase in the interior diameter of axons due to these beading and 
swelling processes. Beading and swelling may disrupt axonal transport in the very early 
stages of mTBI [205,206]. 
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While the NODDI biophysical model is restricted to three non-exchanging 
compartments, the microstructure of the brain is much more complicated. Specifically, 
there are multiple constituents within the extra-cellular compartment that may contribute 
to the changes in diffusion metrics observed in this study. Blood brain barrier disruption 
has become a common hallmark of mTBI and would directly influence the extra-cellular 
space [207]. This disruption has been shown to occur extremely quickly, as early as 
minutes after injury in pre-clinical studies, and further shown to persist for years in 
clinical populations [208–211]. As the blood brain barrier becomes compromised due to a 
mTBI, various constituents such as blood borne proteins thrombin and fibrinogen are free 
to enter the brain [38,212]. If these enter the extra-cellular space surrounding neurons, 
they could contribute to diffusion changes that are indicative of a reduction in the extra-
cellular space. Since the intra-cellular and extra-cellular space varies inversely, reduced 
extra-cellular space would lead to increased intra-cellular space and consequently an 
increase in the NDI metric as observed in the current study. Furthermore, this infiltration 
of the extra-cellular space has been linked to microglial activation and the production of 
pro-inflammatory factors [209,212]. 
Another component that must be considered in the interpretation of the NDI metrics is the 
potential indirect contribution of glial cells. Neuroinflammatory processes have been 
shown extensively in traumatic brain injury, including microglial activation and 
astrocytic hypertrophy [48,61]. While glial cells are much smaller than neurons, they 
outnumber them considerably [213], and the bulk effect on the scale of our voxels could 
contribute to the metrics observed in this study. Neuroinflammatory processes could lead 
to reduced extra-cellular space as glial cell infiltration occurs in the extra-cellular space. 
Furthermore, the morphological features of glial cells vary widely under normal and 
pathological conditions, leading to altered geometric properties [214,215]. On the scales 
present in rodent microstructure, it is possible that the diffusion processes within and near 
activated glial cells could cause a shift in the intra-cellular to extra-cellular volume 
fractions and the observed change in NDI. Furthermore, in previous studies of rat and 
mouse models of mTBI, compression injury, and BBB disruption, it has been shown that 
microglia can respond within minutes by activating and undergoing morphological 
changes [216–219]. However, the evidence to support this early glial response is 
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extremely limited in mTBI models, and more commonly microglial activation is 
discussed within 3-6 hours of injury and beyond [220,221]. Therefore, it is possible that 
changes in glial cell morphology could produce an increase in the measured NDI but this 
interpretation requires thorough histological validation to confirm such an early 
neuroinflammatory response.  
Orientation dispersion index (ODI), characterizes the spatial coherence or dispersion of 
neurites. In the current study, ODI was also increased in the corpus callosum at the initial 
timepoint post injury compared to baseline and continued to increase over time post-
injury suggesting less coherence (greater dispersion) over time. In a single study in mice, 
it was previously shown that an increase in glial cell load correlated with an increase in 
ODI [222]. Therefore, the increase in ODI observed in the current study in the corpus 
callosum could indicate an increase in glial cell density and altered morphology in the 
injury group, but would be considered extremely early for a glial cell response of this 
nature. Similar to the increase in glial cell population contributing to a change in ODI, the 
infiltration of blood borne proteins due BBB disruption may lead to the observed increase 
in ODI. It is currently unknown whether BBB disruption changes the measured NODDI 
metrics in humans or pre-clinical models. A detailed histological analysis would be 
required to determine whether these BBB disruptions occurred in the current model. 
Interestingly, there were no statistically significant changes observed in the current study 
in any of the conventional DTI metrics characterizing the corpus callosum or 
hippocampus. This result is consistent with the existing literature, where there is a 
paucity of work to characterize DTI changes in the first hours following mTBI.  In 
previous studies examining mTBI in rats and traumatic axonal injury (TAI) in mice, 
statistically significant changes in diffusion metrics were detected in the corpus callosum 
in the acute phase (4-6 hours) following injury. [21,176] The earliest timepoints 
examined in these studies were 4-6 hours post-injury, which corresponds approximately 
to the latest timepoint examined in the current study. It seems that DTI metrics may able 
to detect microstructural changes in more aggressive trauma models or at later timepoints 
but may lack the sensitivity to detect very early changes in mTBI models. 
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3.5 Limitations 
One of the common challenges with the interpretation of changes in dMRI metrics is 
determining a microstructural basis for the detected change of each metric. Various dMRI 
techniques have been used to study mTBI, but the results have been largely inconsistent, 
leading to varied interpretations of the underlying biological processes, and providing 
limited diagnostic or clinical utility [104,119,120,223–226]. While NODDI provides 
biologically relevant metrics in terms of the underlying structure, it requires careful 
interpretation. Particularly difficult is the fact that the intra-cellular and extra-cellular 
volume fractions intrinsically vary inversely [29]. Thus, any interpretation of the increase 
in NDI in the current study must also consider the possibility that a decrease in the extra-
cellular volume fraction may be responsible. We have presented several possible 
biological processes that may occur individually or in concert that could lead to 
microstructural changes detectable by NODDI, however these changes were not 
confirmed with histology, which was beyond the scope of this study. While neuroimaging 
has many strengths, particularly the ability to provide in-vivo quantitative tissue 
characterization, it is dramatically limited in resolution when compared to histological 
analysis. With careful histology, the changes observed in this study could potentially be 
attributed to specific biological processes occurring in the brain. This association would 
in turn allow future clinical and pre-clinical studies to infer these changes on the basis of 
a given NODDI metric change.  
Additionally, the current NODDI biophysical model fails to take into account glial cell 
contributions to the diffusion signal. It is conceivable that these contributions could be 
uniquely separated based on glial cell geometry, allowing a more clearly defined picture 
of the entire microstructural environment. Further, while NODDI metrics have been 
shown to have minimal dependency on axon diameter [29], this has not been expressly 
validated on pre-clinical models or ultra-high field systems. It should also be noted that 
during our image processing steps, the registrations were visually inspected for quality 
but no attempt was made to quantify image registration performance, such as a Dice 
index [227].  
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Finally, the current injury protocol did not include measures of injury kinematics, or 
subsequent behavioural impairment and cognitive defects. Thus, there could be an 
unknown bias or heterogeneity present in the imaging metrics observed that could be 
explained by varied brain injury. Future studies would benefit from the characterization 
of these aspects of injury.  Furthermore, as anaesthesia is needed for all rodent MRI 
studies we induce an unknown bias to all studies as isoflurane anaesthesia has been 
shown to attenuate both positively and negatively the neuroinflammatory response 
[228,229] and blood brain barrier permeability [230–232]. While we account for the 
effect of anaesthesia separately with our control group, we cannot fully account for the 
interaction effect of the injury response and anesthesia.  
3.6 Conclusions 
Increased neurite density and orientation dispersion were detected in the corpus callosum 
and hippocamps of a rodent model by neurite orientation dispersion imaging in the initial 
hours following a mild traumatic brain injury.  These microstructural changes were 
detected by NODDI in the absence of changes in traditional DTI metrics, demonstrating 
NODDI to have greater sensitivity to tissue changes immediately following injury. 
 
  
74 
 
3.7 Supplement 
 
Figure 3.7 - Complete processing and analysis steps for diffusion data. 
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Figure 3.8 – A) Corpus callosum (Red) and hippocampus (blue) binary ROI masks 
generated and projected against the Waxholm Sprague Dawley Space Atlas template B) 
Representative corpus callosum (red) and hippocampus (blue) binary ROI masks linearly 
and non-linearly transformed from atlas space into diffusion space.   
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Chapter 4  
4 Neurite Orientation Dispersion and Density Imaging (NODDI) 
in a Rodent Model of Repetitive Mild Traumatic Brain Injury. 
4.1 Introduction 
Mild traumatic brain injury (mTBI) has become a major health concern over the past few 
decades with a substantial increase in the awareness of the detrimental health effects 
associated with this injury [233]. Of particular concern is the increase in repetitive mTBI, 
especially amongst young athletes. Repetitive mild traumatic brain injuries can occur in 
athletes over the course of a sporting season and can lead to long-term debilitating 
symptoms, neurological impairment, and death [11,234–236]. Unfortunately, much like 
an initial traumatic brain injury, very little is understood about the underlying 
pathophysiological features of repetitive mTBI [237–239]. Current clinical tests are 
limited in their diagnostic and prognostic capabilities which leads to a vague 
understanding of the dangers associated with such injuries and limits the acceptance of 
legislation such as return to play guidelines for athletes [240–242]. It is important to 
develop unbiased patient-specific metrics that clinicians may use to diagnose, monitor, 
and grade the severity of repetitive mild traumatic brain injuries so that the long-term 
consequences associated with such injuries can be assessed.  
While conventional imaging techniques such as Computed Tomography (CT) or 
structural magnetic resonance imaging (MRI) do not detect mTBI, advanced MRI 
techniques such as diffusion magnetic resonance imaging (dMRI) have shown promise in 
the detection and monitoring of mTBI [243–245]. Diffusion magnetic resonance imaging 
is a magnetic resonance imaging modality that is sensitive to the displacement pattern of 
water molecules in biological tissue. Many dMRI techniques provide valuable metrics by 
which to determine subtle changes to the tissue microstructure, the most common of 
which is diffusion tensor imaging (DTI) [246]. DTI has been used extensively in the 
study of brain injury and has shown changes in various diffusion metrics such as 
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fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial 
diffusivity (RD) [103,224]. While these metrics can indicate the presence and location of 
a change in the underlying tissue microstructure, they often require careful interpretation 
due to the inherently non-specific nature of DTI metrics. Thus, a more complete 
biophysical model is necessary to capture the vast amount of information encoded within 
a dMRI signal and reconstruct it in a biophysically relevant manner. To this end various 
reconstruction techniques have been proposed to describe the complicated 
microstructural environment in the brain and additionally capture various 
pathophysiological processes, one of which is neurite orientation dispersion and density 
imaging (NODDI).  
NODDI applies an advanced biophysical model to partition the diffusion signal into 
several unique structural elements to quantify various microstructural features such as 
neurite density or orientation dispersion [29]. By measuring these microstructural 
features, NODDI is able to disentangle multiple aspects of the diffusion MR signal and 
monitor changes in these features independently. NODDI models three non-exchanging 
tissue compartments denoted as the cerebrospinal fluid (CSF), intra-neurite, and extra-
neurite compartments. During signal processing, the CSF compartment is modelled as 
isotropic free diffusion (Gaussian) and separated from the total signal. The CSF volume 
fraction is captured by the NODDI metric IsoVF. The remaining signal is partitioned 
between the intra-neurite and extra-neurite compartments. The intra-neurite fraction is 
modelled as cylinders of zero-radius dispersed according to the Watson Distribution and 
water diffusion within this region is highly restricted and directional. Physically this 
represents the signal originating within the dendrites and axons and is quantified by the 
metric neurite density index (NDI). NDI ranges as a scalar value from 0-1. The extra-
neurite fraction is modelled as hindered Gaussian diffusion and represents diffusion near 
neurites, and within cells bodies including various types of glial cells. Note that the extra-
neurite volume fraction is simply 1-NDI, and thus the intra-neurite and extra-neurite 
volume fractions vary inversely and provide complementary information. Finally, 
NODDI provides the orientation dispersion index (ODI) metric. This index ranges from 
0-1 and measures the dispersion and organization of neurites from highly coherently 
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organized and directional (values near 0, e.g. white matter of the corpus callosum) to 
widely dispersed (e.g. grey matter with values near 1).  
Previous work using dMRI to study repetitive mTBI has shown that measurable changes 
in diffusion metrics occurs and that these often do not correlate with patient symptoms, or 
lack thereof [13,247,248]. Furthermore, in pre-clinical models it has been shown that 
repetitive mTBI’s can produce altered diffusivity profiles within white matter tracts that 
follow a pattern of amplification analogous to a dose response to multiple hits [249]. No 
published studies have used dMRI to explore the immediate effects of repetitive mTBI on 
diffusion measurements, but pre-clinical studies have found altered diffusion profiles 
within 4 hours of mTBI in a rat model [176] and traumatic axonal injury (TAI) in a 
mouse model [21]. While the injury models differed for these studies, they highlighted 
the potential for dMRI to detect early changes in the microstructural environment due to 
injury. To our knowledge, NODDI has never been applied to any model of repetitive 
mTBI in either clinical or pre-clinical imaging. NODDI has been used in a select few 
clinical studies of traumatic brain injury and concussion, but with largely varied results. 
Churchill et. al. showed changes in NDI and ODI in various regions such as the corona 
radiata and corpus callosum of athletes with a previous history of concussion compared 
to controls [118]. Further study revealed that in athletes scanned within 7 days of a 
diagnosed concussion, NDI was reduced in regions such as the corona radiata and 
longitudinal fasciculus, and that this reduction persisted past the time that the athletes 
were cleared to return to play [175].  
Recently, we applied NODDI and DTI in the extremely early stages of a pre-clinical 
model of mTBI and showed that NODDI was successfully able to detect changes in NDI 
and ODI within the first two hours post injury in the corpus callosum and hippocampus 
[250]. These changes were not detected with traditional DTI metrics, such as FA, MD, 
AD and RD. Thus, NODDI provides a unique opportunity to explore microstructural 
changes within the brain immediately following both an initial and secondary mTBI.  In 
the current study, we aim to extend our understanding of the early stages of brain injury 
by applying NODDI to a pre-clinical model of repetitive mTBI. We hypothesize that 
NODDI would be sensitive to changes in the microstructural environment of rodents 
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within the first hour of both a primary mild traumatic brain injury and a secondary mild 
traumatic brain injury. Furthermore, we hypothesize that the response to the secondary 
impact will be greater than that observed following the initial impact. Finally, we 
hypothesize that NODDI metrics would be more sensitive to tissue microstructural 
changes than traditional DTI metrics at these early timepoints.  
4.2 Methods 
The injury model, imaging acquisition parameters, processing, registration, and statistical 
analysis methods used in the current study were identical to those listed in the previous 
chapter to ensure direct comparisons could be made. These sections have been repeated 
here for completeness. 
4.2.1 Subjects 
12 adult male Wistar rats (injury: n = 8, age at baseline scan: 112 ± 13 days, weight at 
baseline scan: 278 g ± 38 g, control: n = 4, age at baseline scan: 123 ± 24 days, weight at 
baseline scan: 313 ± 51 g) were acquired from Charles River. Each animal was randomly 
assigned to either the control or injury group. All animal procedures were approved by 
the University of Western Ontario Animal Use Subcommittee and were consistent with 
guidelines established by the Canadian Council on Animal Care. Each animal was 
scanned four times over 14 days according to the following timepoints: 7 days prior to 
injury 1 (Timepoint 1), 1-2 hours after injury 1 (Timepoint 2), 4 days after injury 1 
(Timepoint 3), and 1-2 hours after injury 2 (Timepoint 4). Timepoint 4 occurred 7 days 
after timepoint 2.   
 
Figure 4.1 - Timeline of data acquisition for animals randomly assigned to the injury 
group which received both a primary and secondary closed skull controlled cortical 
impact. 
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4.2.2 Injury 
Similar to our previous study, we chose to use the closed skull controlled cortical impact 
(CCI) due to its pathophysiological response spectrum and thoroughly documented use in 
rat mTBI models [189–192]. Animals were anaesthetized by induction with 4% 
isoflurane followed by maintenance with 2% isoflurane. Each animal was placed in a 
Kopf mouse anesthesia mask (David Kopf Instruments, LLC, USA) under a traumatic 
brain injury device (TBI 0310, Precision Systems and Instrumentation, LLC, USA). For 
each impact, the device was programmed to impact at an intended depth of 3.0 mm, a 
velocity of 3.5 m/s and a 500-millisecond dwell time. The impact region for each animal 
was shaved prior to impact. Each animal received a single closed skull controlled cortical 
impact, centered at the sagittal suture, with a custom-made, 7 mm-diameter, pliant, 
silicone tip. This injury model used here is in line with previous models using closed 
skull controlled cortical impact to induce a mTBI [193–198]. Following controlled 
cortical impact animals, anesthesia was maintained at 2% isoflurane and, using an in-
house built portable induction chamber, each animal was transferred to the small animal 
MRI facility. Control animals were anaesthetized 20 minutes prior to their MRI to match 
the anesthesia time between induction and scan initiation in the injured animals. 
4.2.3 Acquisition 
Images were acquired using a 9.4 T Bruker small animal MRI scanner at the Centre for 
Functional and Metabolic Mapping located within the Robarts Research Institute at the 
University of Western Ontario. Imaging included the acquisition of high-resolution 
anatomical images and NODDI in all animals.  Anatomical images were acquired for 
each subject at the beginning of each session using a T2-weighted TurboRARE pulse 
sequence (8 averages, 32 slices, slice thickness = 500 µm, FOV 32 x 32 mm, matrix size 
160 x 160, in-plane resolution = 200 x 200 µm, TE = 44.00 ms, TR = 7.0 s, Echo Spacing 
= 11.00 ms, Rare Factor 8, total acquisition time = 14 min)[199].  The NODDI diffusion 
sequence was incorporated into a multi-shot, spin echo, echo-planar-imaging (EPI) 
acquisition pulse sequence (4 shots, 32 slices, slice thickness = 500 µm, FOV 40 x 40 
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mm, matrix size 160 x 160,  in-plane resolution = 250 × 250 µm, TE = 26.71 ms, TR = 
2.5 s). 
The NODDI diffusion scheme used was previously described in detail and was shown to 
produce reproducible and reliable results at 9.4 Tesla [200]. Briefly, a q-space sampling 
scheme was used across two-shells, optimized according to Caruyer et. al. [146], with a 
total of 90 directions.  In shell one, 30 directions with b-value = 1000 s/mm2 were 
obtained using the following diffusion gradient parameters: gradient strength 
(G) = 172.85 mT/m, time between the start of the first and second diffusion pulse 
(Δ) = 14 ms, the duration of a single gradient pulse (δ) = 4.5 ms.  In shell two, 60 
directions with b-value = 2000 s/mm2 were obtained using the following diffusion 
gradient parameters: gradient strength (G) = 345.70 mT/m, time between the start of the 
first and second diffusion pulse (Δ) = 14 ms, the duration of a single gradient pulse 
(δ) = 4.5 ms.   Ten b = 0 s/mm2 were interspersed evenly throughout the acquisition. Four 
averages were used to ensure adequate signal to noise ratio (SNR) in the higher b-value 
shell. The imaging time for each acquisition (four averages) was 66 minutes 36 seconds. 
A single reverse phase encoded b=0 volume was also acquired prior to the diffusion 
sequence for subsequent use in image processing to correct image distortions.  
4.2.4 Processing 
Brain masks were produced using the 3D Pulse Coupled Neural Network (PCNN) tool 
for MATLAB (R2019a) [150]. Raw data were pre-processed using fMRI Software 
Library (FSL, v. 6.0.1, Oxford, UK). TOPUP [148] followed by EDDY [149] was used to 
correct for eddy current induced distortions as well as susceptibility-induced distortions. 
The FDT toolbox (v. 5.0) was used to produce maps of FA, MD, AD, and RD. The 
NODDI Matlab toolbox (available from the University College London (UCL) 
Microstructure Imaging Group) was then used to produce maps of NDI, ODI, and IsoVF. 
All diffusion maps were produced within each subject’s native diffusion image space. 
While IsoVF is produced during the processing steps, our previous work has indicated it 
to have extremely high variability and low reproducibility with this scan protocol and 
therefore we limit our analysis to NDI and ODI only. 
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4.2.5 Registration 
For each subject, the first volume in each diffusion data set (b = 0) was aligned with its 
corresponding anatomical images using a linear registration in FSL (FLIRT) [151]. The 
anatomical image for each subject was then aligned to the Waxholm Space Atlas Sprague 
Dawley template [152] using a linear transformation (FLIRT) followed by a non-linear 
transformation (FNIRT) [153] in FSL. Binary ROI masks of the corpus collosum and 
hippocampus from the Waxholm Space Atlas, were then transformed into the anatomical 
space of each individual subject by inverting the preceding non-linear transformations. 
Finally, the masks were brought into diffusion space using the inverse transformation 
matrix from the b0 image to anatomical image registration. Thus, each mask was brought 
into each subject’s individual native diffusion image space. Each mask was then eroded 
by a single voxel around the edges to avoid partial volume effects. Masks were visually 
inspected to ensure accuracy.  Please refer to 3.7 for processing steps and representative 
visualizations of ROI binary masks.  
4.2.6 Statistical Analysis  
For each subject, at each timepoint the mean value of each individual scalar metric within 
each relevant ROI was extracted using fslstats and the relevant binary mask. A mixed 
ANOVA in SPSS [201] was used for each metric to determine if there were statistically 
significant interaction effects (p < .05) between controls and injured animals over time.  
This test examined whether each metric changed over time and whether those changes 
were different between the two groups. Mauchly’s Test was used to determine if the 
assumptions of sphericity were violated. In cases where the assumption of sphericity was 
rejected, the Greenhouse-Geisser correction was used. In each case where a statistically 
significant interaction effect occurred, a follow-up repeated measures ANOVA was run 
separately on each group (injured and controlled) to determine if there were statistically 
significant changes (p < .05) in the diffusion metric over time within each group. Further, 
post-hoc analysis was used to determine which timepoints differed within each group 
(Bonferroni corrected). Finally, in an effort to determine if the response to each hit 
differed in those metrics which showed a statistically significant change from baseline, a 
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paired t-test on the response to injury 1 and injury 2 was used. The response to injury 1 
was defined as the difference between timepoint 1 and 2, while the response the injury 2 
was defined as the difference between timepoint 3 and 4. 
4.3 Results  
Data were successfully acquired from all 12 subjects. Figure 4.2depicts single subject raw 
data, NODDI scalar maps, and DTI scalar maps. The following timepoints were used in 
this study: Timepoint 1 (or baseline scan) obtained 7 days prior to injury, Timepoint 2 
began at 62 ±  14 minutes post-injury 1, Timepoint 3 began at 98 ± 3 hours post-injury, 
and Timepoint 4 began at 66 ± 11 minutes post-injury 2. 
 
Figure 4.2 - Single-subject axial slices of A) raw diffusion data B) Neurite Density Index 
(NDI), C) Orientation Dispersion Index (ODI), D) Isotropic Volume Fraction (IsoVF), E) 
Fractional Anisotropy (FA), F) Mean Diffusivity (MD), G) Axial Diffusivity H), Radial 
Diffusivity. The diffusion images were acquired with a multi-shell  sequence (10 b= 0 
s/mm2, 30 b = 1000 s/mm2 and 60 b= 2000 s/mm2) incorporated into a multi-shot, spin 
echo, echo-planar-imaging (EPI) acquisition pulse sequence (4 shots, 32 slices, slice 
thickness = 500 µm, FOV 40 x 40 mm, matrix size 160 x 160,  in-plane resolution = 250 
× 250 µm, TE = 26.71 ms, TR = 2.5 s). 
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4.3.1 Corpus Callosum 
 
Figure 4.3 – Mean ROI metrics within the corpus callosum for injured and control 
subjects. Each data point depicts the mean value of an individual subject ±  SEM. Note, 
injury 1 took place at timepoint 1 and injury 2 took place at timepoint 4. For NDI and 
ODI in the corpus callosum a mixed effects ANOVA in SPSS showed a statistically 
significant group by time interaction (p < .05). A repeated measures ANOVA was then 
used to determine individual differences amongst the injured and control groups. Post-
hoc pairwise comparisons (Bonferroni corrected) were then determined between 
individual timepoints within each group. Statistically significant (p < .05) pairwise 
differences are indicated by *.  
In the Corpus Callosum, there was a statistically significant (p < .05) group by time 
interaction effect for NDI [F(3,30) = 4.161, p = .033, Greenhouse-Geisser corrected] and 
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ODI [F(3,30) = 3.851, p = .047, Greenhouse-Geisser corrected]. There was no 
statistically significant interaction effect (p > .05) of group by time for FA, MD, AD and 
RD. 
From the subsequent univariate repeated measures ANOVA, it can be seen that for both 
NDI and ODI there was a statistically significant change over time for the injured group, 
while no statistically significant change over time occurred within the control group for 
these metrics. 
Table 4.1 - Mean ROI diffusion metrics that were shown to be significantly different 
between injured and control subjects. Values shown are mean ± SD. 
Metric Timepoint Injured Control 
NDI 1 0.524 ± 0.008 0.530 ± 0.010 
2 0.540 ± 0.009 0.539 ± 0.014 
3 0.539 ± 0.020 0.537 ± 0.011 
4 0.558 ± 0.017 0.536 ± 0.013 
ODI 1 0.303 ± 0.014 0.323 ± 0.017 
2 0.340 ± 0.012 0.327 ± 0.015 
3 0.322 ± 0.023 0.326 ± 0.016 
4 0.322 ± 0.027 0.325 ± 0.019 
Table 4.2 - Statistical Results of a repeated measures ANOVA for NDI and ODI within 
the corpus callosum. All statistical analysis was run in SPSS (v. 26). 
Metric Statistical Results 
NDI Injured F (3,21) = 13.618 p = .001 Greenhouse-Geisser 
Control F (3,9) = 1.318 p = .328 Sphericity Assumed 
ODI Injured F (3,21) = 9.504 p = .000 Sphericity Assumed 
Control F (3,9) = 3.431 p = .066 Sphericity Assumed 
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Figure 4.4 - Mean ROI values in the injured group of NDI and ODI within the corpus 
callosum. Note, injury 1 took place at timepoint 1 and injury 2 took place at timepoint 4.  
For every individual subject in the injured group, an increase in both NDI and ODI 
occurred from baseline to the first mTBI. Following this individual response varied 
across the subsequent timepoints. 
Similar to our previous study, it can be seen that for every individual subject both ODI 
and NDI increased after the initial mTBI. Using and two-tailed paired t-test it was shown 
that for NDI there was no statistically significant difference in the response to injury 1 
and injury 2 in the corpus callosum (p = .68). For ODI there was a statistically significant 
difference in the response to injury 1 and injury 2 (p =.00)  
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Table 4.3 – NDI and ODI values for each subject in the corpus collosum of the injured 
group. There was no statistically significant difference between D1 and  D2 for NDI 
indicating a similar response to injury 1 and injury 2. For ODI a statistically significant 
difference between D1 and  D2 existed (p =.00). 
Metric Subject Injury 1 Injury 2 
Timepoint 
1 
Timepoint 
2 
D1 Timepoint 
3 
Timepoint 
4 
D2 
NDI 1 0.517 0.536 0.019 0.543 0.543 0.000 
2 0.531 0.551 0.020 0.539 0.562 0.023 
3 0.521 0.545 0.024 0.536 0.556 0.019 
4 0.526 0.547 0.021 0.544 0.542 -0.002 
5 0.512 0.525 0.013 0.506 0.540 0.0346 
6 0.522 0.538 0.016 0.518 0.555 0.0373 
7 0.525 0.530 0.005 0.567 0.588 0.0208 
8 0.537 0.547 0.010 0.557 0.574 0.0163 
Mean 0.524 ± 
0.008 
0.540 ± 
0.009 
0.016 ± 
0.006 
0.539 ± 
0.020 
0.558 ± 
0.017 
0.019 ± 
0.014 
ODI 1 0.282 0.320 0.037 0.300 0.335 0.035 
2 0.307 0.343 0.035 0.329 0.327 -0.001 
3 0.301 0.336 0.034 0.310 0.299 -0.010 
4 0.310 0.353 0.042 0.334 0.301 -0.034 
5 0.310 0.339 0.029 0.299 0.311 0.012 
6 0.294 0.328 0.035 0.301 0.293 -0.008 
7 0.327 0.355 0.028 0.364 0.376 0.012 
8 0.292 0.349 0.057 0.340 0.338 -0.002 
Mean 0.303 ± 
0.014 
0.340 ± 
0.012 
0.037 ± 
0.009 
0.322 ± 
0.023 
0.322 ± 
0.027 
0.004 ± 
0.020 
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4.3.2 Hippocampus 
 
Figure 4.5 - Mean ROI metrics within the hippocampus for injured and control subjects. 
Each data point depicts the mean value of an individual subject ±  SEM. Note, injury 1 
took place at timepoint 1 and injury 2 took place at timepoint 4. No statistically 
significant group by time interactions (p > .05) were detected.  
In the hippocampus, there was no statistically significant interaction effect (p > .05) of 
group by time for NDI, ODI, FA, MD, AD and RD. As no group by time interaction 
effect occurred in the hippocampus no subsequent statistical analysis was performed. 
Please refer to Figure 4.5 for ROI values. 
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4.4 Discussion 
This study examined the immediate changes in NODDI and DTI metrics in a rodent 
model of repetitive mild traumatic brain injury. The NODDI metrics NDI and ODI 
showed statistically significant increases in the corpus callosum within the first two hours 
after the initial mTBI, while only NDI showed a further increase immediately following 
the second mTBI one week later.  There were no changes in any diffusion metrics in the 
hippocampus.  The increase in NDI in the corpus callosum suggests a change in the 
microstructural environment immediately following each mTBI. However, converse to 
our hypothesis, there were no changes in diffusion metrics that were greater following the 
second injury compared to the first injury on a group level.  Interestingly, individual 
response to the second mTBI varied substantially. 
Neurite density index (NDI) was shown to increase immediately following the initial 
mTBI and the second mTBI in the corpus callosum. Following the initial injury, an 
average increase in NDI of 0.016 ± 0.006 (3.22%) was found and following the second 
injury and average increase of 0.0187 ± 0.014 (3.41%). This result agrees with our 
previous study which also showed an increase of 0.046 ± 0.026 (7.83%) in NDI 
compared to baseline in the corpus collosum [250]. Further, it was shown that the 
response to injury 1 did not significantly differ from the response to injury 2 in the corpus 
collosum. When referring to the mean values of NDI over time we see (in order): 0.524, 
0.540, 0.539, 0.558 (refer to  
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Table 4.3). From this we may infer that the pathophysiological response that NDI has 
measured did not resolve between injury 1 and injury 2 (noting there was no significant 
difference between timepoint 2 and 3), and that the second injury in fact compounded on 
the first with equal magnitude. This finding could provide a clue as to the dose-like effect 
of multiple mTBI’s often seen in the clinical setting. 
Common interpretations of increased NDI suggest an increase in the volume or number 
of dendrites and axons within the corpus callosum. The most likely explanation would be 
an increase in the inner diameter of axons due to axonal swelling and beading. Axonal 
swelling and beading have been shown by ex-vivo histology as a common 
microstructural change in mTBI [167,251,252]. In addition, these pathological processes 
have been shown to occur within as little as thirty minutes following injury in mTBI 
models [56,171]. Therefore, the increase in NDI following both the first and second 
mTBI in the current study could be due to these processes.  Furthermore, in the current 
study it was shown that four days after the initial impact, NDI was not statistically 
different than baseline, suggesting that the effect of the initial mTBI on NDI had, at least 
in part, resolved in the intervening time. 
While the NODDI biophysical model technically encompasses strictly the tissue 
components of the microstructure, there are significantly more components contained 
within the diffusion signal. Specifically, the various constituents in the extra-neurite 
compartment must be considered as this is inversely related to NDI (e.g. an increase in 
NDI could be due to a decrease in the extra-neurite space). Blood brain barrier disruption 
been extensively shown in mTBI and this disruption has been shown to occur as early as 
minutes after injury in pre-clinical studies [208–211]. This disruption compromises the 
ability of the BBB to restrict passage of various factors such as blood borne proteins from 
entering the extra-neurite space [38,212]. As these enter the extra-neurite space 
surrounding neurons, they could contribute to diffusion changes that are measured as a 
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reduction in the extra-neurite space, thus contributing to the increases observed in the 
NDI measurement.  
Neuroinflammatory processes have been heavily implicated in the initial and long-term 
response to mTBI [72,253,254]. It has been shown that the response is complex, at times 
acting in a neuroprotective manner, and others in a neurodegenerative manner [255–257]. 
Furthermore, as shown in Figure 3, it appears that the NDI  response and its outcome 
vary dramatically on an individual basis, consistent with the heterogeneous individual 
response to mTBI seen in patients [258,259]. In the current study it is possible that 
increased glial cells within the extra-neurite compartment contributed to a decrease in the 
volume of the extra-neurite compartment. As the extra-neurite and intra-neurite NDI 
components must sum to unity, this would lead to the measured increase in NDI apparent 
here. Additionally, the glial cell response has been shown to occur minutes after injury in 
various brain injury models such as TBI and BBB disruption [216–219]. Once again, 
these processes could lead to a reduction in the extra-neurite compartment and the 
measured NDI increase. Of particular interest in the discussion is the heterogeneous 
response of NDI in individuals following the first mTBI. While each individual subject 
showed an increase in NDI following the initial hit, the changes observed on day four 
varied widely amongst individuals.  As discussed in our previous paper, while the 
relationship between NDI and neuroinflammation is an interesting possibility, a 
detectable glial response is more commonly thought to begin within 3-6 hours post mTBI 
[220,221] and further confirmation through histology would be needed to support this 
interpretation.   
Orientation dispersion index (ODI) also increased in the corpus callosum from baseline to 
our initial timepoint post injury consistent with our previous study. Following the initial 
injury, an average increase in ODI of 0.037 ± 0.009 (10.88%). This increase was no 
longer present four days after impact.  Interestingly, there was no further increase in ODI 
following the second mTBI.  As described previously, the increase in ODI following the 
first injury indicates an increase in the dispersion of white matter tracts within the corpus 
callosum, leaving them less ordered along their predominant fiber direction. Axonal 
disorganization has been heavily implicated in mTBI, showing altered anisotropy 
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amongst fiber bundles and decreased alignment [260–262].  There are several other 
potential explanations for this change including the infiltration of blood constituents to 
the extra-neurite space, although there is currently no literature exploring the relationship 
between ODI and BBB disruption. Additionally, it has been shown that an increase in 
glial cell load correlates to an increase in ODI and thus it is possible that a 
neuroinflammatory response may account for the measured changes [222]. However, as 
discussed previously it is unlikely the glial response accounts for the measured signal 
change at the very early time point examined in the current study. Here again it is 
extremely important to acknowledge the heterogenous ODI response following the initial 
timepoint. Following the initial mTBI, the measured changes in ODI on an individual 
basis (Figure 3) vary substantially potentially indicating a varied individual response to 
trauma.  
No statistically significant changes were observed in NDI or ODI in the hippocampus. 
This result was surprising as our previous study detected an increase in NDI but not ODI 
immediately following a single mTBI. It should be noted though that while the previous 
increase in NDI in the hippocampus was statistically significant, the magnitude was only 
0.022 ± 0.021 (3.93%) at the earliest timepoint. Further, the earliest timepoint in our 
previous study began at 75 ± 16 minutes, while in the current study the earliest timepoint 
began at 62 ± 14 minutes. While this is not a large time difference in relation to the 
overall scan time of 66 minutes, it is possible that at these extremely early timepoints and 
the very small magnitude of change, the NDI changes observed in the first study did not 
have time to develop in the current study. Future studies would benefit by looking into 
this change with larger sample sizes and precisely matched timepoints.    
It is also noteworthy that no statistically significant changes were observed in any DTI 
metrics in the corpus callosum or hippocampus following either the first or repeated 
mTBI. This agrees with our previous findings indicating that using the current scan 
protocol DTI lacks the sensitivity to detect diffusion changes immediately following 
mTBI [250]. 
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4.5 Limitations 
While dMRI techniques are highly sensitive to subtle changes in diffusion parameters, 
the results must be carefully interpreted to make inferences with regard to the underlying 
microstructural changes [263,264]. NODDI uses a biophysical model to partition the 
diffusion signal into physically relevant compartments, but still requires interpretation as 
it does not account for various constituents of the extra-neurite compartment such as glial 
cell contribution to the diffusion signal. In the current study we have provided possible 
biological explanations that could contribute to the measured signal changes, but these 
would require careful histological validation. It may also be possible in the future to 
partition the NODDI model further, thus separating out the unique diffusion 
characteristics of glial cells such as microglia and astrocytes. This would prove 
immensely valuable in the study of brain injury and neurodegeneration, of which 
neuroinflammation has been heavily implicated. Furthermore, it should be noted that 
while NODDI has been heavily validated for human studies at clinical field strengths, 
some characteristics such as axon diameter dependency in rodents at ultra-high fields 
have not been expressly explored. While we have shown these metrics to be reproducible 
in a rodent model at 9.4 Tesla, it would be useful to further validate the metrics 
specifically at this field strength [200].  
The current injury protocol did not take into account careful examination of the kinematic 
properties of the injury, such as sheer forces and acceleration. Additionally, no 
behavioural measures were taken to determine cognitive defects associated with this 
injury. When observing the heterogenous individual response to the second injury in this 
model, it would be extremely valuable to have this additional information, such that any 
covariance in the injury model may be accounted for. While the impact was consistent 
amongst subjects, adding this covariance could account for individual differences in the 
result of that impact. Finally, it would be beneficial to track these subjects for several 
weeks following repetitive mTBI’s to determine long-term outcomes and relate to the 
individual responses seen in the current study. This in turn could shed light on the 
immense variance seen in terms of recovery in the clinical patient population. 
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4.6 Conclusions 
NODDI was successfully able to detect changes in NDI and ODI in the brain of rodent’s 
immediately following a first and a second closed skull controlled cortical impact. The 
measured changes largely did not differ between the first and second impact when 
comparing groups but varied dramatically on an individual basis. This leads us to 
conclude the immediate response to repetitive mTBI is extremely heterogeneous and 
could provide clues with regard to the varied recovery rates evident in the clinical patient 
population. 
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Chapter 5  
5 Summary and Conclusions 
5.1 Overview and Research Questions 
Mild traumatic brain injury (mTBI) is known to contribute to a diverse range of short- 
and long-term detrimental health effects, ranging from nausea and dizziness to extreme 
memory loss, mental health issues, and death [44,265,266]. Currently, there is no 
pathognomonic test that allows clinicians to diagnose, assess the severity, or monitor the 
recovery of patients suffering from a mTBI. Most medical imaging techniques are unable 
to detect mTBI as large scale changes such as expanding epidural hematoma are not 
present [5,6]. Further, it is nearly impossible to study the immediate changes in a clinical 
setting because patients simply are not available to study during this time period. Thus, 
the complete pathological response occurring in the early stages of mTBI is still largely 
unknown, limiting diagnosis, prognosis, and development of treatment.  
One medical imaging modality that has shown promise in the detection of microstructural 
changes in mTBI is neurite orientation dispersion and density imaging (NODDI). NODDI 
is a biophysical modelling technique that separates a dMRI signal into three unique 
compartments termed the intra-neurite, extra-neurite, and CSF compartments [30]. This 
model allows detection of microstructural changes, such as axonal beading, separate from 
changes within the extra-neurite compartment, such as neuroinflammatory effects, 
providing a unique imaging perspective on the various pathological processes taking 
place in the immediate stages following mTBI. 
The overreaching objective of this thesis was to apply NODDI in the early stages of a 
rodent model of mTBI at 9.4 Tesla in an effort to understand and quantify the 
pathophysiological response to mTBI. Specifically, this thesis addressed three main 
research questions: 1) What is the scan-rescan reproducibility of NODDI in a rat model at 
9.4 Tesla, and what biological effects is NODDI capable of detecting with feasible pre-
clinical sample sizes? (Chapter 2); 2) Is NODDI capable of detecting changes within 
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early stages of a rat model of mTBI, and if so, what underlying physiological processes 
do they represent? (Chapter 3); and 3) Is NODDI capable of detecting changes 
immediately following both a first and second injury in a rodent model of mTBI, and is 
this response to injury different (Chapter 4)? 
5.2 Chapter Summaries and Significance 
5.2.1 Chapter 2 
In Chapter 2, the reproducibility of NODDI in a rodent model at 9.4 Tesla was evaluated. 
Eight adult male Sprague Dawley rats were subjected to a scan-rescan protocol on a 9.4 
Tesla Agilent MRI. The coefficient of variation (CV) was used to assess the 
reproducibility and reliability of NODDI and provide insight into necessary sample sizes 
and the minimum detectable effect size. NDI and ODI showed high reproducibility both 
between and within subjects under both a voxel-wise and ROI analysis. Furthermore, it 
was found that small biological changes (< 5%) may be detected with feasible sample 
sizes (n < 6-10). In contrast, IsoVF was found to have low reliability and reproducibility, 
requiring very large sample sizes (n > 50) for biological changes to be detected. This 
work represents the first publication quantifying the reproducibility of NODDI metrics at 
9.4 Tesla in a rat brain and provides valuable insights as to the number of subjects 
necessary to detect a given biological effect. 
5.2.2 Chapter 3 
With NODDI shown to be reproducible and capable of detecting subtle changes with 
feasible sample sizes, NODDI was applied to a rodent model of mTBI to determine 
whether microstructural changes could be detected immediately following injury. 
Secondary to this we sought to compare the sensitivity of NODDI metrics to standard 
DTI metrics in this model. Nine adult male Wistar rats underwent a single closed skull 
controlled cortical impact followed immediately by NODDI repeated three times from 1-
4 hours post injury. Six sham control rats were scanned under the same conditions 
without injury. ROI analysis showed a statistically significant increase in NDI in both the 
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hippocampus and corpus callosum following injury, while ODI showed an increase in 
only the corpus callosum. These changes occurred at the first timepoint post-injury (≈ 1 
hour) and stayed elevated through the final timepoint (≈ 4 hours). No statistically 
significant changes were observed in the sham control animals for NDI, nor ODI. No 
statistically significant changes were found in FA, MD, AD, or RD metrics in either 
group. These metrics indicate an immediate change to the microstructural architecture in 
the brain following mTBI and provide insight into the pathophysiological response to 
injury. Further, these results indicate that NODDI metrics are more sensitive than DTI 
metrics to early microstructural changes in the current injury model. This study 
represented the first application of NODDI to a pre-clinical rodent model of mTBI at 9.4 
Tesla, and the first study to investigate alterations in diffusion metrics within the first 4 
hours post-mTBI. 
5.2.3 Chapter 4 
In Chapter 4, we extended this model of mTBI to determine the response to repetitive 
mTBI in a rodent model using NODDI. Eight adult male Wistar rats underwent two 
closed skull controlled cortical impacts followed immediately by a NODDI acquisition 1-
2 hours post injury. The impacts were separated by one week. Animals were scanned at 
four separate timepoints: 1 week before injury, immediately following the first mTBI, 
four days following the first mTBI, and immediately following the second mTBI. In 
injured animals, both NDI and ODI showed a statistically significant increase 
immediately following the first mTBI in the corpus callosum. NDI showed a similar 
increase following the second mTBI in the corpus callosum while ODI did not. No 
statistically significant changes were observed in the hippocampus of injured animals nor 
any region in the sham control animals. Furthermore, no statistically significant changes 
were found in FA, MD, AD, or RD metrics in either group. The observed changes 
support our previous findings showing an immediate change to the microstructure of the 
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brain following an initial mTBI and suggest further disruption of the tissue microstructure 
following the second mTBI. Of particular note in this study was the heterogeneous 
individual response to injury following the second mTBI. This finding could provide 
insight into the widely varied outcomes and recovery amongst the clinical population 
exposed to multiple mTBI. This study represented the first application of NODDI to a 
pre-clinical rodent model of repetitive mTBI at 9.4 Tesla, and the first study to 
investigate alterations in diffusion metrics immediately following mTBI in any 
application.  
5.3 Limitations 
In this section, I discuss the major limitations of the chapters individually followed by a 
discussion of general limitations of the thesis. 
5.3.1 Chapter 2 
There are several limitations to acknowledge within this study, the first of which is the 
fact that the quality of the linear and non-linear registrations was not specifically 
quantified. While they were visually assessed for quality, future studies may benefit from 
quantification of the registration process with Dice index analysis [227]. Secondly, 
optimized parameters such as angular resolution, image resolution, and b-value 
combination for rodent NODDI at 9.4 Tesla has not been fully explored. While these 
considerations must be balanced against practicalities such as scan time for any in-vivo 
study, it would be beneficial to do a thorough quantification and comparison of these 
parameters. In humans, the optimal b-values were explored through simulation and in-
vivo study, and it was found that as long as two shells with moderate b-value were used, 
the precise choice of b-value made minimal difference and was minimally affected by 
axon diameter [29]. Future studies would benefit from a similar analysis within a rodent 
brain at 9.4 Tesla. 
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5.3.2 Chapter 3 and 4  
These chapters follow the same experimental protocol and thus have the same limitations. 
Similar to Chapter 2, these studies suffer from lack of image registration quantification 
and NODDI parameter optimization. Additionally, they are limited by the absence of 
histological validation. As the NODDI reconstruction is limited to a 3-compartment 
model, it fails to uniquely account for contributions from pathophysiological processes 
such as blood-brain barrier disruption or glial cell response. It could be that these 
processes contributed to the changes observed in this study, but without histological 
validation, any interpretation is uncertain. Future studies would benefit from a careful 
histological analysis. Additionally, no behavioral measures were acquired to determine if 
the injury model used did in fact produce a mTBI. The varied response on an individual 
level could possibly be explained in part by behavioural analysis of the subjects. Finally, 
while the controlled cortical impact was landmarked and standardized for each injury, no 
metrics were obtained quantifying kinematic properties such as rotation and translation of 
the head. These metrics could be integral in further explaining sources of variation in the 
resulting NODDI metrics.  
5.3.3 General Limitations 
Over the course of this thesis, significant upgrades took place within the lab, one of 
which was the upgrade from an Agilent 9.4 Tesla scanner to a Bruker 9.4 Tesla scanner. 
Thus, the work in Chapter 2 was performed on the former system while the work in 
Chapter 3 and 4 was performed on the latter system. This included entirely new 
hardware, software, pulse sequences, data storage, and raw data reconstruction. Basic 
SNR calculations were performed on a small number of data sets showing improved SNR 
with the Bruker system (≈ 20%), but a thorough quantification of NODDI performance 
between the two systems was not performed. It should also be noted that in Chapter 2, 
Sprague Dawley rats were used, while in Chapter 3 and 4, Wistar rats were used due to 
protocol limitations. While we do not anticipate a large change in results between the two 
strains, it is important to note the difference.   
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5.4 Future Directions 
5.4.1 NODDI Optimization at 9.4 Tesla 
In Chapter 2 of this thesis, NODDI was shown to be reproducible and sensitive to small 
changes in NDI and ODI metrics. Although this allowed these parameters to be used for 
future studies, it is currently unknown if they are in fact the optimal parameters. As such 
the optimization of the NODDI acquisition at 9.4 Tesla would provide a valuable 
framework for future studies. Specifically, this study would focus on the optimization of 
angular resolution, b-value magnitude, and b-value distribution amongst and between 
shells. Furthermore, this would provide optimized protocols under set scan times, which 
could be achieved on common 9.4 Tesla preclinical scanners. The same approach used to 
optimize NODDI acquisition in humans could be applied to optimize the acquisition in 
rodents [29,267]. This work would provide a road map for researchers to apply NODDI 
to extensive preclinical applications. 
5.4.2 Histological Validation of NODDI Metric Changes Observed 
Following mTBI 
As stated in both Chapter 3 and 4, the major limitation in these studies involves 
interpretation of the observed changes in NODDI metrics. To overcome this, careful 
histological validation would be necessary to confirm these findings. We propose 
repeating these studies with a larger cohort and a greater histological focus. Specifically, 
we propose amyloid precursor protein (APP) immunohistochemistry and silver staining 
to characterize axonal pathology [195], ionized calcium-binding adaptor protein-1 (IBA-
1) immunohistochemistry to characterize microglial activation [268], Glial fibrillary 
acidic protein (GFAP) to detect astrogliosis [269,270], and the evaluation of BBB 
disruption through the use of Immunoglobulin G (IgG) staining [271] and Evans Blue 
extravasation assay [272]. By performing each of these stains, we would be able to 
disentangle the information contained in the NODDI metrics, leading to a more thorough 
understanding of how the pathophysiological response contributes to these changes.  
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5.4.3 Combined PET/MRI to Visualize Microglial Activation in mTBI 
Microglial activation has been shown as an important neuroinflammatory response to 
brain injuries such as mTBI [73,273]. Activation can occur within hours and persist many 
years, often occurring at sites of neuronal degeneration and axonal alterations [274–276]. 
As such, non-invasive in-vivo imaging of microglial activation presents a unique 
possibility to measure a component of the neuroinflammatory response to injury. The 
PET ligand [18F]-DPA-714 binds with high specificity to TSPO, an 18-kDa translocator 
protein [277]. Activation of microglia leads to increased mitochondrial TSPO expression, 
while expression of TSPO under normal physiological conditions is relatively low and 
restricted to specific regions [278,279]. Due to the specific binding affinity, ability to 
cross the blood-brain barrier, and negligible levels of endogenous [18F]-DPA-714, it is a 
prime candidate to visualize the activation of microglia in-vivo in mTBI [280]. The use of 
combined PET/MRI allows for high-resolution anatomical imaging using MRI, while 
obtaining the dynamic pathophysiological information from PET. Immediately following 
imaging, animals would be sacrificed and immunohistochemistry staining (Iba-1) would 
be used to verify and localize activation of microglia. 
The ability to dynamically image microglial activation will allow for repeated-measures, 
longitudinal studies of various normal and pathological processes, which has previously 
been impossible within histological studies. This in turn could lead to a more thorough 
and accurate understanding of the development and response of the central nervous 
system. 
5.4.4 In-vivo Imaging of Glial Cells using Diffusion Weighted MRI 
Glial cells are the most abundant non-neuronal cell type within the central nervous 
system (CNS) [33]. These cells provide extensive support throughout the brain and spinal 
cord through the maintenance of homeostasis and various supporting activities for the 
neuron [35]. As discussed in this thesis, glial cells are heavily implicated in the response 
to mTBI. Although extensive histological techniques have been developed to visualize 
glial cell load and morphology ex-vivo, in-vivo techniques are sparse. Here, we propose 
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the use of diffusion weighted MRI to dynamically visualize and quantify glial cells in-
vivo in rodents.   
Diffusion weighted MRI would be acquired on an ultra-high field (9.4 Tesla) small 
animal scanner. To reconstruct the signal, we would follow the method employed in the 
NODDI toolbox (available from the UCL Microstructure Imaging Group) with a 
modification to extract the unique contribution from the glial cell compartment. Thus, the 
total diffusion signal would be separated into four non-exchanging microstructural 
compartments: the intra-neurite fraction (volume fraction of water within the axons and 
dendrites), the extra-neurite volume fraction (volume fraction of water near neurons), the 
CSF volume fraction (volume fraction of isotopically free diffusing water), and the glial 
volume fraction (volume fraction of water within the glial cells). While some studies 
have shown the contribution of glial cells to these compartments [222], we currently are 
not aware of any techniques which expressly define the glial cell contribution uniquely. 
Due to the size (approximately one tenth the size of a neuron), we expect diffusion to be 
minimal and non-directional within glial cells, leading to high diffusion signal in regions 
of high glial cell load. This diffusion pattern is unique within the microstructural 
environment when compared to neurons and dendrites (highly restricted and directional), 
the extracellular space (hindered and directional), and the CSF (free, non-directional).  
Initially, simulations could be employed based on those described in [267,281] to 
determine optimal diffusion acquisition parameters based on known glial cell structure. 
These parameters would then be applied to in-vivo rodent models of mTBI. Immediately 
following acquisition, animals would be euthanized and perfused in preparation for 
histology. Established histological stains such as Iba-1 and GFAP would be used to detect 
the presence of glial cells. Reconstructed diffusion images would then be registered and 
validated against histological images. The use of diffusion weighted MRI here will 
address the significant gap that exists between ex-vivo and in-vivo capabilities of imaging 
glial cells. 
103 
 
5.5 Significance and Impact 
mTBI is a diverse and challenging injury to diagnose. Clinical presentations vary 
dramatically, as do patient outcomes [4,265,282]. To this point, the scientific literature 
with regard to mTBI is largely divergent, except to show the potential for debilitating and 
damaging health effects [2,283]. While these health effects are well known now, the 
underlying pathophysiological processes that produce these effects are largely unknown. 
Without a clear understanding of these processes it is impossible for clinicians to 
accurately diagnose and assess mTBI in patients. Neurite orientation dispersion and 
density imaging provides an opportunity to study these microstructural changes in-vivo. 
This thesis advances the capabilities of NODDI in a pre-clinical model of mTBI. When 
this work began, only a single publication had applied NODDI in a preclinical setting 
[144], but the reliability and reproducibility of the technique in this setting was unknown. 
We have provided, for the first time, quantification of the reproducibility of this 
technique at 9.4 Tesla and provided details with regard to the measurable biological 
effect’s detectable with this technique. This information will enable researchers to 
similarly apply this technique to countless pre-clinical models of neuronal health, disease, 
and injury.  
Simultaneously, this thesis advances our understandings of the early microstructural 
changes present in mTBI. Clinically it is impossible to study these changes for the first 
several hours following a brain injury as patients rarely present early following injury and 
if they do, they cannot be kept in a scanner for any appreciable length of time. This thesis 
presents the first application of NODDI in a pre-clinical rodent model of both initial and 
repetitive mTBI at 9.4 Tesla. We have provided, for the first time, in-vivo evidence of 
changes in NODDI metrics detectable within the first hour following both an initial and 
secondary mTBI in a rodent model. These changes indicate detectable underlying 
microstructural changes that occur rapidly after a mTBI. This knowledge indicates the 
potential of NODDI to be further developed into a diagnostic imaging technique capable 
of quantifiably detecting mTBI in-vivo.  
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